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 Florian Mair  1 Summary 
SUMMARY 
 
In order to avoid fatal autoimmunity, the immune system needs to maintain a 
careful balance between reactivity towards invading pathogens, and tolerance 
towards self-antigens. One of the most prominent regulators involved in these 
processes is the transcription factor family of NFκB (nuclear factor kappa-light-chain-
enhancer of B cells). Two main pathways can activate NFκB: the classical, and the 
alternative or non-canonical pathway. In case of the latter the NFκB-inducing kinase 
(NIK) is the most important signal conveyor. 
Signaling via NIK has been shown to be essential for the development of lymph 
nodes and the normal function of many immune cell types, including B cells, 
αβ T cells and dendritic cells (DCs). Therefore, mice deficient for NIK show diverse 
phenotypes in different cellular compartments, which impedes the clarification of the 
role of NIK in one specific cell type. 
Within this thesis, I describe a novel mouse line that allows for conditional deletion 
of NIK in a time- and tissue-specific manner. Using these NIKflox/flox mice we could 
show that NIK signaling plays an essential role both in T cells and DCs for the 
induction of experimental autoimmune encephalomyelitis (EAE), which is the animal 
model for multiple sclerosis (MS). DC-specific deletion of NIK led to an impaired 
ability of DCs to produce pro-inflammatory cytokines, and to a selective loss of skin-
draining Langerin+ DCs in the lymph node. Hence, loss of NIK signaling seems to 
have very discrete effects on the migration and function of DCs. 
Furthermore, we aimed at investigating the development and function of γδ T cells 
in the absence of functional NIK signaling. γδ T cells are increasingly recognized as 
important effector cells at the interface of innate and adaptive immunity, particularly 
due to their ability for immediate secretion of pro-inflammatory cytokines. We found 
that NIK-deficient lymphoid and tissue-resident γδ T cells were selectively impaired 
in their ability for IL-17 production, while their expression of IFN-γ remained 
unchanged. In addition, the pool of dendritic epidermal T cells (DETCs) in the skin of 
NIK-/- mice was disturbed in that most of the DETCs lost expression of the canonical 
Vγ5Vδ1 T cell receptor. This was due to a developmental block of Vγ5+ precursor 
cells in the embryonic thymus, most likely caused by the absence of Skint-1 
expression on NIK-deficient thymic epithelial cells. 
In summary, these results identify a previously unknown role of NIK in the function 
of γδ T cells. In addition, the novel NIKflox/flox mouse line will be a unique tool for 
understanding the function of NIK in different immune compartments in more detail. 
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 Florian Mair  3 Zusammenfassung 
ZUSAMMENFASSUNG 
 
In einem gesunden Organismus ist die Hauptaufgabe des Immunsystems 
eindringende Mikroorganismen zu zerstören. Gleichzeitig muss jedoch gewährleistet 
sein, dass das Immunsystem keine Reaktivität gegenüber körpereigenen Zellen 
zeigt, da sonst gefährliche Autoimmunerkrankungen die Folge sind. Eines der 
wichtigsten Moleküle, die dieses Gleichgewicht regeln, ist der Transkriptionsfaktor 
NFκB. NFκB bezeichnet eine Familie an genregulatorischen Proteinen, die über zwei 
verschiedene Signalwege aktiviert werden, nämlich über den sogenannten 
klassischen und den alternativen Weg. Für die alternative Aktivierung von NFκB ist 
die sogenannte NFκB inducing kinase (NIK) das wichtigste Signalprotein. 
Bisher ist bekannt, dass NIK essentiell für die Entstehung von Lymphknoten ist, aber 
auch für die Funktion von B Zellen, αβ T Zellen und dendritischen Zellen (DCs). Auf 
Grund dieser vielfältigen Funktionen war es bisher schwierig, die Rolle von NIK in 
einzelnen Zelltypen zu untersuchen. 
Im Rahmen dieser Arbeit beschreibe ich einen neuen Mausstamm, der ein zelltyp-
spezifisches Ausschalten des Gens für NIK erlaubt (NIKflox/flox). Mit Hilfe dieser 
NIKflox/flox Tiere konnten wir zeigen, dass Signale via NIK essentiell für die Entstehung 
von experimenteller autoimmuner Enzephalomyelitis (EAE) sind, die üblicherweise 
als Tiermodell für Multiple Sklerose (MS) angesehen wird. Ein spezifisches 
Ausschalten von NIK in DCs führte dazu, dass diese weniger proinflammatorische 
Zytokine produzieren konnten. Außerdem war die Anzahl an Langerin+ DCs im 
hautnahen Lymphknoten drastisch reduziert. Daher schlussfolgern wir, dass NIK eine 
wichtige Rolle für die Migration und Funktion von DCs hat. 
Außerdem wollten wir die Funktion von NIK in einer Zellpopulation prüfen, die in 
diesem Kontext noch nicht eingehend untersucht wurde, nämlich γδ T Zellen. 
Innerhalb der letzten Jahre wurde klar, dass γδ T Zellen wichtige Effektorzellen an 
der Schnittstelle zwischen adaptivem und angeborenem Immunsystem sind, vor 
allem wegen ihrer Fähigkeit schnell pro-inflammatorische Zytokine produzieren zu 
können. Wir konnten zeigen, dass sowohl lymphoide als auch gewebe-ansässige 
γδ T Zellen kein Interleukin-17 mehr produzieren konnten, während ihre Fähigkeit 
zur Produktion von Interferon-γ unbeeinträchtigt war. Außerdem zeigten Vγ5+ 
dendritische epidermale T Zellen (DETCs) Unregelmäßigkeiten, die wir auf eine 
Blockade in der Entwicklung von Vγ5+ Vorläuferzellen zurückführen konnten. 
Kurz zusammengefasst zeigen diese Experimente, dass NIK eine bisher unbekannte 
Rolle in der Funktion von γδ T Zellen hat. Vor allem aber wird das konditionale 
Mausmodell (NIKflox/flox) ein nützliches Werkzeug sein, um die Funktion von NIK 
innerhalb des Immunsystems genauer zu untersuchen. 
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 Florian Mair  5 Abbreviations 
ABBREVIATIONS 
 
 
Ab   antibody 
Ag  antigen 
APC   antigen presenting cell 
approx.  approximately 
BBB  blood brain barrier 
β-ME   β-mercaptoethanol 
BM  bone marrow 
BMC  bone marrow chimera 
bp   base pair  
BSA   bovine serum albumin 
°C   temperature in degrees Celsius 
CCL  chemokine ligand 
CCR  chemokine receptor 
CD   cluster of differentiation 
CFA   Complete Freund’s Adjuvant 
CFSE  carboxyfluorescein succinimidyl ester 
cDNA   complementary DNA 
CNS   central nervous system 
Cre   LoxP site-specific recombinase 
CTL  cytotoxic T lymphocyte 
d   day/s 
DC   dendritic cell 
DNA   desoxyribonucleic acid 
dNTP   desoxynucleotide triphosphate 
EAE   experimental autoimmune encephalomyelitis 
EDTA   ethylene-diaminetetraacetic acid 
ELISA   enzyme-linked immuno-sorbent assay 
ES cell  embryonic stem cell 
EtOH   ethanol 
FACS   fluorescence activated cell sorting 
FCS   fetal calf serum 
Fig.   Figure 
Flp   FRT site-specific recombinase 
FoxP3   forkhead box protein 3 
FRT   Flp recombination target 
g   gram 
GFP  green fluorescent protein 
GM-CSF granulocyte/macrophage-colony stimulating factor 
h   hour/s 
HEPES  N-2-hydroxyethylpiperazine-N’-2-ethansulfonic acid 
HLA  human leukocyte antigen 
i.p.   intraperitoneally 
i.v.   intravenously 
IFN-γ   interferon-γ 
Ig   immunoglobulin 
IL   interleukin 
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IRES  internal ribosome entry site 
LN   lymph node/s 
loxP   recognition sequence for Cre 
LPS   lipopolysaccharide 
M   molar 
MACS   magnetic activated cell sorter 
MBP  myelin basic protein 
MFI   mean fluorescence intensity 
MgCl2   magnesium chloride 
MHC   major histocompatibility complex 
min   minute 
ml   milliliter 
mM   millimolar 
MOG   myelin oligodendrocyte glycoprotein 
mRNA   messenger RNA 
MS   multiple sclerosis 
MΦ   macrophage/s 
n   nano 
NaCl   sodium chloride 
NaOH   sodium hydroxide 
Neo(R)  neomycin resistance gene 
o/n   over night 
PBS   phosphate buffered saline 
PCR   polymerase chain reaction 
pDC  plasmacytoid dendritic cell 
PP  Peyers patch 
Ptx   Pertussis toxin 
RAG   recombination activating gene 
RNA   ribonucleic acid 
rpm   revolutions per minute 
RT   room temperature 
sec   seconds 
s.c.   subcutaneously 
SD  standard deviation 
SEM  standard error of mean 
SN   supernatant 
Taq   polymerase from Thermus aquaticus 
TCR   T cell receptor 
TE   Tris-EDTA buffer 
TEC   thymic epithelial cell 
tg   transgenic 
TGFβ   transforming growth factor-β 
TH cell  helper T cell 
TLR  toll-like receptor 
Tregs   regulatory T cells 
µl   microliter 
µM   micromolar 
3’   three prime end of DNA sequences 
5’   five prime end of DNA sequences 
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INTRODUCTION 
 
THE IMMUNE SYSTEM 
The term “immune system” covers all molecular and cellular mechanisms that an 
organism uses to defend itself against invading pathogens and resulting disease. For 
higher vertebrates, the immune system consists of a complex network of specialized 
cells and organs, but even simple unicellular organisms such as bacteria use 
enzymes to protect themselves for example from bacteriophage infections. 
In the case of all jawed vertebrates, the immune system can be divided into two 
mechanistically distinct units, namely innate and adaptive immunity. The innate 
immune system primarily relies on pattern recognition receptors (PRRs), which 
recognize evolutionary conserved structures on pathogenic organisms, so called 
pathogen associated molecular patterns (PAMPs). Beside that, innate immune cells 
are also able to sense stress signals sent out from injured or damaged cells. 
Hence, the innate immune system can react immediately to a wide range of 
pathogens, but neither offers specificity (beyond the recognition of PAMPs) nor 
immunological memory. As a result, vertebrates have evolved the adaptive immune 
system, which is not only able to recognize any invading organism in a highly 
specific manner, but also offers immunological memory. For the purpose of this 
thesis, we will focus on the function of the immune system in mammals, with a main 
emphasis on the murine immune system as a representative model for human 
immune responses. 
 
THE INNATE IMMUNE SYSTEM 
Innate immunity represents the evolutionary older arm of the immune system, 
which provides immediate defense against a wide range of invading pathogens in a 
non-specific way.  
In simplified terms, the innate immune system can be divided into three parts: 
physical barriers, the complement system and innate immune cells. Epithelial 
surfaces provide the first line of defense against any intruder, and if not injured, the 
lung, gut and skin epithelium represent very tight and impermeable physical 
barriers. While the purpose of epithelia obviously extends beyond their role as 
immunological barriers, the complement system evolved solely as a primitive 
defense system. It consists of a variety of plasma proteins, which can either lead 
directly to the destruction (lysis) of pathogens, or rather recruit additional immune 
cells (reviewed in (Fujita, 2002)). 
Introduction 8 Florian Mair 
Prototypic innate immune cells are natural killer cells (NK cells), mast cells, 
eosinophils, basophils and neutrophils. Dendritic cells (DCs) and macrophages are 
phagocytic cells of the innate immune system that are able to engulf and destroy 
pathogens, but these two cell types fulfill additional roles in activating adaptive 
immunity, as will be discussed further below. 
 
THE ADAPTIVE IMMUNE SYSTEM 
Compared to innate immunity, adaptive immunity has two additional key features: 
First, the ability to recognize almost any possible microbial structure in a highly 
specific way, and second, the ability to memorize prior encounters for mounting a 
faster and stronger secondary response. This property has been termed 
immunological memory (Ahmed and Gray, 1996). 
The cells of the adaptive immune system are T and B lymphocytes. The latter are 
generated in the bone marrow and are responsible for the production of antibodies, 
thereby being major players in the so-called humoral immune response. In contrast, 
T cells are generated in the thymus and are the main players in cellular immune 
responses. The principal functions of T cells are the activation and regulation of 
other immune cells by the secretion of soluble messenger molecules termed 
cytokines, and the lysis of virus infected cells. 
The exceptional feature of T and B cells is their expression of a unique antigen 
receptor, namely the T cell receptor (TCR) and the B cell receptor (BCR). However, 
there is a major difference in the mode of antigen recognition: T cells are 
recognizing peptide antigens, which need to be presented by antigen presenting 
cells such as dendritic cells (DCs) in the context of the major histocompatibility 
complex (MHC) after processing of the protein (van der Merwe and Davis, 2003). In 
contrast, B cells are able to recognize soluble antigens in their naïve form without 
the need for further processing. 
So how can adaptive immune cells be able to recognize virtually any antigen without 
prior encounter? The key mechanism underlying this phenomenon is the random 
somatic gene rearrangement of a number of DNA fragments (the variable, diversity 
and joining loci, VDJ) during lymphocyte development (Fugmann et al., 2000). It is 
estimated that together with additional means to increase receptor diversity, namely 
junctional diversity during joining of the V, D and J loci, up to 1011 to 1015 different 
amino acid sequences for the BCR and TCR, respectively, can be generated. 
Due to the random nature of this process, not all of the resulting amino acid 
sequences will provide useful receptors. On top of that, some of these receptors will 
be recognizing self-antigen, i.e. molecules present in the organism itself. As a result, 
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the repertoire of developing adaptive immune cells needs to be selected carefully, 
which will be discussed in more detail in subsequent chapters. 
 
LYMPHOID TISSUES 
From an evolutionary perspective, the advent of adaptive immune cells concurred 
with the appearance of lymphoid tissues (Hofmann et al., 2010). In higher 
vertebrates, lymphoid tissues are not only the place where immune cells develop, 
but more importantly provide a specialized microenvironment that allows the 
efficient interaction between innate and adaptive immune cells. Three types of 
lymphoid tissues can be distinguished: primary lymphoid tissues (PLTs) are the bone 
marrow (BM) and the thymus, secondary lymphoid tissues (SLTs) include lymph 
nodes (LNs), the spleen and Peyer´s Patches (PPs), and tertiary lymphoid tissues 
are simple lymphoid structures that can develop in situations of chronic inflammation 
(Aloisi and Pujol-Borrell, 2006). 
The bone marrow is the principal site where hematopoietic stem cells (HSCs) reside, 
which will give rise to all cells of the hematopoietic lineage including erythrocytes, 
myeloid and lymphoid cells (reviewed in (Cumano and Godin, 2007)). B cells derive 
from a lymphoid progenitor, and will continue to develop in the bone marrow. In 
contrast, T cells, which also derive from a common lymphoid progenitor in the bone 
marrow, will mature in the thymus. The process of T cell development will be 
discussed in more detail in the following chapters. 
Different to the bone marrow and the thymus, lymph nodes and spleen provide 
specialized anatomical structures to favor the initiation of adaptive immune 
responses by bringing innate and adaptive immune cells into close proximity (Junt et 
al., 2008). These two main SLTs differ in their precise function: the spleen primarily 
samples blood-borne antigens, while lymph nodes are positioned strategically to 
collect the draining fluid from certain peripheral tissues. Peyer´s patches in turn are 
comparably smaller lymphoid structures that are not connected to the lymphoid 
drainage system and are only found in the gut, where they sample antigen from the 
gut lumen. 
Despite their different functions, the basic building blocks of spleen and lymph node 
are comparable: an outer “antigen-sampling” zone containing large numbers of 
antigen-presenting cells (mostly DCs), and distinct inner T and B cell zones (Junt et 
al., 2008). During homeostasis, T cells will circulate throughout all lymphoid tissues 
and scan antigen-presenting cells for their cognate antigen. Upon recognition of 
their target, they will get activated and initiate an adaptive immune response. 
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INITIATING AN ADAPTIVE IMMUNE RESPONSE 
Usually, the purpose of an immune response is to combat and ultimately eliminate 
an intruding pathogen, often a microbe or a virus.  
In a nutshell, there are three steps during an adaptive immune response: first, the 
invading pathogen will encounter tissue-resident innate immune cells, among them 
DCs. These sense the invader via pattern recognition receptors, followed by 
activation, and phagocytosis and processing of foreign antigens. Activated DCs 
migrate to the draining lymph node and upregulate expression of MHC class II and 
costimulatory molecules. Following the arrival in the draining LN, circulating T cells 
get into contact with DCs, and after recognition of their cognate antigen via the TCR 
become activated. It is thought that full T cell activation requires three signals: the 
antigen, costimulation via the CD28-CD80/86 axis and polarization via cytokines 
(Gutcher and Becher, 2007). This process is usually referred to as the priming phase 
of an immune response, and lack of costimulatory signals can result in T cell anergy, 
i.e. unresponsiveness towards the antigen. 
 
 
 
 
 
 
 
 
 
 
The second phase of an adaptive immune response is the so-called effector phase: 
antigen-specific T cells and B cells will undergo clonal expansion, which is one of the 
reasons why it takes several days until adaptive immunity reaches its full efficiency. 
During their activation, T cells will also undergo functional differentiation towards a 
certain effector program, leave the lymph node and migrate to the site of 
Figure 1: Three signal-hypothesis for the activation of T cells. 
After formation of the immunological synapse between antigen-presenting cell (APC) and 
T cell, three signals are needed for full T cell activation and differentiation: first, recognition 
of the cognate peptide antigen presented by MHC class I or II molecules. Second, 
costimulation via membrane bound surface receptors of the B7-family, primarily CD80 and 
CD86. Third, polarization signals via cytokines will dictate the differentiation of activated 
T cells towards a particular effector lineage. 
Ag: antigen. TCR: T cell receptor. MHC: major histocompatibility complex. 
(picture modified from Gutcher et al, JCI 2007)  
 Florian Mair  11 Introduction 
inflammation. There, the invading pathogen will be combated by a variety of effector 
mechanisms, usually involving both adaptive and innate immune cells. In fact, one 
of the main roles of adaptive immunity is to enhance and steer the effector functions 
of innate immunity. 
The third phase of an immune response is the return to homeostasis and formation 
of memory. Most of the expanded antigen-specific T and B cells will die by 
apoptosis, while some of them will become memory cells, that persist in the bone 
marrow or the periphery and during secondary stimulation can expand and react 
very rapidly (reviewed in (Mueller et al., 2013) and (McHeyzer-Williams and 
McHeyzer-Williams, 2005)). 
Within the scope of this thesis we will focus mainly on DCs, and T cells and their 
effector mechanisms, which include secretion of cytokines for activation of other 
immune cells, lysis of target cells, and also regulation of immune responses. 
 
THE OTHER SIDE OF THE COIN: AUTOIMMUNITY 
As already mentioned, the receptor repertoire of adaptive immune cells is generated 
by a largely random process that inevitably will generate receptors capable of 
recognizing self-antigen, i.e. constituents of the organism itself. Several mechanisms 
have evolved to remove this potentially dangerous specificities from the T cell and 
B cell repertoire during development, some of which we will discuss in further detail 
below (Boehmer and Melchers, 2010). Also, so-called dominant tolerance 
mechanisms exist, such as immunosuppressive immune cell subsets and the 
induction of anergy, which is the unresponsiveness of adaptive immune cells 
towards certain antigens (Fathman and Lineberry, 2007). 
However, if any of these machineries fails, attack of self-antigen by the immune 
system will lead to autoimmune disease, which has already been proposed by the 
visionary Paul Ehrlich at the beginning of the 20th century, back then termed “horror 
autotoxicus”. By now it is known that the most prominent autoimmune diseases 
include diabetes mellitus type 1, systemic lupus erythematosus (SLE), rheumatoid 
arthritis, Grave´s disease and multiple sclerosis (MS) (reviewed in (Steinman, 1995). 
In Western civilisations, up to 5% of the population suffer from autoimmune 
pathologies. 
Hence, it is indispensable to understand the molecular mechanisms that enable and 
drive autoimmunity in order to develop treatment strategies. Within this thesis we 
will discuss only one the above-mentioned diseases, namely MS and its animal 
model experimental autoimmune encephalomyelitis (EAE). Before we do so, we will 
explain the function and development of T cells, and the mechanisms that ensure 
immunological tolerance in a healthy individual. 
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αβ  T CELLS 
It was only in the 1960s that bulk lymphocytes were separated into B and T cells 
based on their functionally distinct roles in humoral and cellular immunity (Miller and 
Mitchell, 1967). Roughly 10 years later the first sub-classification of T cells based on 
their differential expression of Ly antigens was proposed (Cantor and Boyse, 1975; 
Kisielow et al., 1975). By now it is well established that two main classes of αβ 
T cells exist, which can be distinguished based on the surface expression of different 
CD (cluster of differentiation) molecules: CD8+ cytotoxic T cells and CD4+ helper 
T cells (TH cells). 
CD8+ T cells recognize peptide antigens in the context of MHC class I molecules and 
are able to directly lyse target cells via cytotoxic granules, which is a critical effector 
mechanism for the clearance of virus-infected cells (Wong and Pamer, 2003). In 
contrast, CD4+ T cells recognize peptide antigens bound to MHC class II. Their main 
role is the secretion of soluble messenger molecules termed cytokines that shape 
the subsequent immune response, and the provision of help to B cells and CD8+ 
T cells (Zhu et al., 2010). Prior to the encounter with their cognate antigen, 
CD4+ T  cells are referred to as “naïve”, and antigen recognition in combination with 
additional signals will trigger not only their activation, but also their differentiation 
towards a certain effector profile. 
A seminal step forward in the functional understanding of CD4+ T cells was achieved 
in 1986, when Coffman and colleagues characterized different CD4+ T cell clones 
based on their expression of the effector cytokines Interferon-γ (IFN-γ) and 
Interleukin-4 (at this time known as B cell stimulating factor 1). IFN-γ producing 
T cells were termed TH1 cells, and IL-4 producing T cells became known as TH2 cells 
(Mosmann et al., 1986). This early dogma of helper T cell differentiation became 
widely accepted, but in the past decade several additional sub-classes of CD4+ 
T cells have been identified, including immunosuppressive regulatory T cells. The 
phenotypic properties as well as the effector mechanism of these subsets will be 
discussed in more detail in the next section. 
 
αβ T CELL EFFECTOR LINEAGES AND SIGNATURE CYTOKINES 
The past decade has witnessed the discovery of many additional subsets of CD4+ 
T helper cells in addition to the classical TH1 and TH2 lineages, namely TH17 cells, 
follicular helper T cells (TFH) and natural and inducible regulatory T cells (Tregs). 
However, whether these T cell lineages (which have been mostly based on the 
signature cytokines produced) really represent a terminal differentiation state in 
vivo, or whether there is functional plasticity depending on the current 
microenvironment is a matter of intense debate (Zhou et al., 2009). 
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The differentiation towards the TH1 lineage is thought to be induced by IL-12, which 
is produced by activated DCs. Naïve T cells sensing IL-12 (in addition to TCR 
stimulation) will activate a signaling cascade via the signal transducer and activator 
of transcription 4 (STAT-4) (Kaplan et al., 1996), leading to activation of the T box 
transcription factor T-bet, which is considered to be the master regulator of TH1 cells 
(Szabo et al., 2000). Functionally, TH1 cells aid the eradication of intracellular 
bacteria by production of IFN-γ, but also IL-2 and Lymphotoxin-α (LTα). IFN-γ, the 
signature cytokine of TH1 cells, acts as a major activator of macrophage 
phagocytosis. 
In contrast, TH2 differentiation requires signaling via IL-4 and STAT-6 (Kopf et al., 
1993), leading to activation of the transcription factor GATA-3 (Zheng and Flavell, 
1997). The signature cytokines of TH2 cells are IL-4, IL-5 and IL-13, and the main 
function of TH2 cells is the induction of humoral (i.e. antibody mediated) immunity, 
thereby leading to the containment of extracellular pathogens. Also, production of 
IL-5 by TH2 cells will activate eosinophils to attack parasites like helminthes. 
Notably, for both T cell lineages the secreted signature cytokines will reinforce their 
given differentiation state: IFN-γ and IL-2 further activate T-bet expression in TH1 
cells, while IL-4 reinforces GATA-3 expression and suppresses TH1 development by 
blocking IL-12 receptor expression (Ouyang et al., 2000; Szabo et al., 1997). 
The TH1-TH2 dogma dominated research on the function of T helper cells for over 20 
years, until it was shown that stimulation of naïve T cells in the presence of IL-23 
leads to secretion of IL-17, a cytokine which is produced neither by TH1 nor TH2 cells 
(Aggarwal et al., 2003). In 2005, the term TH17 cell was first used to describe these 
T cells, which led to the dawn of a third T helper cell lineage (Harrington et al., 
2005; Langrish, 2005; Park et al., 2005). Shortly later, it was revealed that the 
orphan nuclear receptor RORγt is necessary for the generation of IL-17 producing 
T cells (Ivanov et al., 2006). However, the receptor for IL-23 (IL23-R) is not 
expressed on naïve T cells, but only upregulated after stimulation in the presence of 
IL-6 (McGeachy et al., 2007; Zhou et al., 2007). 
The main reason why TH17 cells attracted a huge interest among immunologists is 
the fact that this subpopulation of T cells has been implicated in various models of 
autoimmunity, for most of which IL-23 was shown to be a non-redundant player 
(Croxford et al., 2012; Cua et al., 2003; Langrish, 2005). We will discuss the role of 
pathogenic T cells in autoimmunity in subsequent chapters. 
Roughly at the same time as IL-23, the forkhead/winged helix transcription factor 
FoxP3 was discovered as being a master regulator for the development of regulatory 
T cells (Tregs) (Fontenot et al., 2003; Hori et al., 2003; Khattri et al., 2003). While it 
has already been known for a while that CD25hi CD4+ T cells have 
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immunosuppressive capacity (Sakaguchi et al., 1995), the discovery of FoxP3 firmly 
established the existence of a regulatory T cell population. In the mouse model, 
both complete deletion of FoxP3 as well as depletion of FoxP3+ Tregs causes fatal 
autoimmunity (Kim et al., 2007). Notably, while the major fraction of FoxP3+ Tregs 
is thought to arise in the thymus (nTregs), naïve T cells can be converted to induced 
Tregs (iTregs) in vitro by stimulation with TGF-β (Chen et al., 2003). Seminal 
experiments utilizing in vivo stimulation with low doses of antigen in the absence of 
costimulation further supported the notion that Tregs can be induced peripherally 
(Kretschmer et al., 2005). 
T follicular helper (TFH) cells differ from the subsets mentioned above in that they do 
not participate in the effector phase of an immune response directly, but instead 
promote the so-called affinity maturation of B cells during the later stage of an 
adaptive immune response. Affinity maturation of B cells occurs in the germinal 
centers (GCs) of lymph nodes and relies on a process called somatic hypermutation 
(Odegard and Schatz, 2006). TFH cells are characterized by expression of the 
chemokine receptor 5 (CXCR-5) and depend on IL-21 and STAT-6 signaling for their 
differentiation, but as for other T cell subsets it is not yet clear whether these cells 
represent a distinct lineage (Nurieva et al., 2008). 
 
γδ  T CELLS 
Both CD4+ and CD8+ T cells express a dimeric TCR that consists of a clonally 
variable α and β chain. After a long and elusive search by many immunologists, 
these chains were identified and cloned in the mid 1980s (Hedrick et al., 1984; Saito 
et al., 1984). Shortly after that, it was reported that there are T cells expressing 
alternative TCR chains, namely the γ and δ chain (Garman et al., 1986; Heilig and 
Tonegawa, 1986). In subsequent years it became evident that γδ T cells represent a 
separate T cell lineage distinct from αβ T cells, with a peculiar enrichment in 
epithelial tissues (Allison and Havran, 1991). Nevertheless, the immunological 
community mainly ignored γδ T cells, most likely because of their low abundance in 
lymphoid organs and the lack of appropriate tools to study their function (Hayday, 
2000). Only in the past decade it became obvious, that γδ T cell have unique 
features that place them at the interface of the adaptive and the innate immune 
system (Vantourout and Hayday, 2013). This notion was further corroborated by the 
recent finding that in lampreys, which are primitive jawless vertebrates, a 
lymphocyte lineage exists that resembles mammalian γδ T cells in terms of 
development and function (Hirano et al., 2013). Hence, already in the last common 
vertebrate ancestor roughly 500 million years ago, evolution has shaped three 
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primordial lymphocytes lineages (B cells, αβ T cells and γδ T cells) with comparable 
functional properties that have been conserved since then. 
The most notable difference between αβ T cells and γδ T cells is that the latter are 
not restricted to recognizing peptide-MHC complexes. Several qualitatively different 
antigens have been proposed, including phospho-antigens (Constant et al., 1994), 
MHC-related proteins including so-called stress antigens (Crowley et al., 1997; Shin 
et al., 2005) and lipids. Very recently, it has been reported that both human and 
murine γδ T cells can bind to Phycoerythrin, an algal fluorescent protein, which is 
also recognized by B cells (Zeng et al., 2012). However, the full scope of antigens 
that can be recognized by γδ T cells is still a matter of intense research (Vantourout 
and Hayday, 2013). 
Another extraordinary difference to αβ T cells is that many γδ T cell populations 
show a restricted TCR diversity. This is particularly striking because the 
combinatorial diversity of the γδ gene locus would in theory be even larger than the 
one of the αβ locus, namely 1020 receptor specificities (compared to theoretical 1015 
receptors for αβ T cells) (Carding and Egan, 2002). Hence, some mechanism must 
ensure that the γδ T cell repertoire is focused on few specificities, and it is still 
unclear how this is achieved (Vantourout and Hayday, 2013).  
In addition, γδ T cells of a given TCR specificity often directly home to particular 
tissues with only minor recirculation through the lymphatic system. One prime 
example of this phenomenon are so-called dendritic epidermal γδ T cells (DETCs), 
which are found only in the murine epidermis and show a nearly monoclonal 
expression of a Vγ5+Vδ1+ TCR (Asarnow et al., 1988). Another example are Vγ6+ γδ 
T cells, that home primarily to the lung and the reproductive tract, and Vγ7+ γδ 
T cells that populate the intestine (Vantourout and Hayday, 2013). Also in the 
human system, γδ T cell populations of limited diversity have been described, such 
as the Vγ9+Vδ2+ pool in the peripheral blood (Triebel et al., 1988). 
As will be discussed in subsequent chapters, γδ T cells differ significantly from αβ 
T cells in that their ability to produce certain pro-inflammatory cytokines is already 
pre-programmed during thymic development. This concept has been put forward by 
several reports (Jensen et al., 2008; Ribot et al., 2009), and was recently 
corroborated by an extensive transcriptome analysis of various γδ thymocytes 
subsets (Narayan et al., 2012), which we will discuss in further detail in the chapter 
on γδ T cell development. 
In the next section we will examine some of the effector functions of γδ T cells, with 
a particular focus on lymphoid stress-surveillance. 
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γδ T CELL EFFECTOR FUNCTIONS 
Similar to αβ T cells, both human and mouse γδ T cells after activation can secrete 
various effector cytokines, including IFN-γ, TNFα, IL-17, but also IL-4 or 
granulocyte-macrophage colony stimulating factor (GM-CSF). Obviously, this allows 
γδ T cells to contribute significantly to an immune response (for example by IL-17 
mediated recruitement of neutrophils), but they do so with different kinetics and 
different efficacy.  
As mentioned above, several γδ T cell populations express a very narrow or even 
monoclonal TCR repertoire, which means that despite being outnumbered by αβ 
T cells as a lineage, the absolute number of γδ T cells recognizing a particular 
antigen is relatively large. Hence, after stimulation via the TCR or via certain 
cytokines, γδ T cells can rapidly mobilize their effector function without the need for 
clonal expansion (Vantourout and Hayday, 2013). 
Based on this fast responsiveness and their ability to recognize stress antigens (such 
as the MHC class 1b protein Rae-1), the term “lymphoid stress-surveillance” has 
been termed (Hayday, 2009). This refers to the ability of γδ T cells to rapidly react 
towards non-microbial stress such as physical perturbations of epithelial cell layers 
or malignant cell transformation. Supporting this hypothesis, TCRδ-/- animals show 
increased susceptibility to carcinogenesis in the skin (Girardi et al., 2001), and in 
certain genetic backgrounds such as FVB or NOD (non-obese diabetic), TCRδ-/- 
animals develop spontaneous dermatitis (Girardi et al., 2002). Also in humans, the 
stress-induced MHC like molecules MICA and MICB were shown to stimulate 
intestinal Vδ1+ γδ T cells (Groh et al., 1996; 1998). 
The link between genotoxic stress and immune responses was emphasized by 
another report in which the DNA damage machinery directly induced expression of 
Rae1 (Gasser et al., 2005). Rae1 is a ligand for the NKG2D (natural killer group 2, 
member D) receptor being expressed by NK-cells, but also by γδ T cells. 
Furthermore, in a genetic mouse model in which Rae-1b expression was induced de 
novo in otherwise healthy skin, both Langerhans cells and dendritic epidermal γδ T 
cells (DETCs) became activated (Strid et al., 2008). Furthermore, DETCs have also 
been implicated in wound healing (Jameson et al., 2002). 
An interesting feature of γδ T cells is that a large proportion constitutively expresses 
the receptor for IL-23 (Awasthi et al., 2009). Thus, in contrast to αβ T cells that 
require prior stimulation, γδ T cells can sense IL-23 immediately and respond by 
production of IL-17 (Sutton et al., 2009), which in turn will induce the recruitment of 
neutrophils to the site of inflammation. There is increasing evidence that this early 
inflammatory response induced by tissue-resident γδ T cells is important for optimal 
control of bacterial infections, as has been shown both in mice and men (Peng et al., 
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2008; Umemura et al., 2007). During infection with Mycobacterium tuberculosis, γδ 
T cells even exceed αβ T cells in terms of production of IL-17 (Lockhart et al., 
2006). Along these lines, γδ T cells were shown to express the Toll like receptors 
TLR1 and TLR2 and also sense bacterial products in vivo (Martin et al., 2009). In 
addition to that, it has been reported that IL-23-induced activation of γδ T cells can 
participate in the pathogenesis of autoimmune models such as psoriatic skin 
inflammation and experimental autoimmune encephalomyelitis (EAE) (Cai et al., 
2011; Pantelyushin et al., 2012; Petermann et al., 2010). 
In summary, the importance of different γδ T cell subsets both during protective 
immune reactions as well as pathologic autoimmune conditions is becoming 
increasingly evident, emphasizing the need to understand the molecular pathways 
regulating their development and function in more detail. 
 
So far we have discussed the basic components of innate and adaptive immunity, 
focusing on different subsets of T cells and their involvement during immune 
responses. In the next chapters we will have a detailed look at T cell development of 
the αβ and γδ lineage, as well as the mechanisms of central tolerance. 
 
T CELL DEVELOPMENT 
While B cell development occurs in the bone marrow, T cell development progresses 
in the thymus, a two-lobed organ situated between the heart and the sternum, 
which can be divided into a cortical and a medullary region and is surrounded by a 
capsule. Historically, the ancient Greek considered the thymus as the seat of the 
soul, and it was only in the early 1960s that Jacques Miller could show by neonatal 
thymectomy in mice that the thymus is essential for the generation of mature T cells 
(Miller, 1961). 
Of note, the thymus does not contain any hematopoietic self-renewing stem cells, 
but is dependent on the import of lymphoid progenitor cells from the bone marrow 
(Foss et al., 2001). These cells enter the thymus at the cortico-medullary junction, 
and within a period of 2-3 weeks have to go through different thymic compartments 
and a complex series of selection events, leaving the thymus as mature CD4+ or 
CD8+ αβ T cells, or mature γδ T cells. Notably, T cell development strongly depends 
on signals derived from different stromal cells present in the thymus, namely cortical 
and medullary thymic epithelial cells (cTECs and mTECS, respectively) and thymic 
dendritic cells (DCs) (Anderson et al., 2007). 
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As they enter the thymus, multipotent lymphoid progenitors (MLPs) are not 
committed to the T cell lineage yet (Porritt et al., 2004). These early thymocytes are 
usually termed double negative (DN) cells due to their lack of CD4 and CD8 
expression, and their T cell receptor genes are still in germline configuration. Based 
on expression of CD25 and CD44 four different developmental stages are typically 
distinguished: DN1 (CD25- CD44+), DN2 (CD25+ CD44+), DN3 (CD25+ CD44low), DN4 
(CD25- CD44low). Within these thymocyte compartments, further subsets with 
defined developmental potential can be identified by the use of additional surface 
markers such as c-kit (CD117) and heat stable antigen (CD24) (reviewed in (Petrie 
and Zúñiga-Pflücker, 2007)). 
Figure 2: Overview of T cell development and the stromal cell types present in the 
thymus. 
As discussed in the main text, T cell precursors will enter the thymus at the cortico-medullary 
junction. Double negative (DN) cells migrate towards the capsule and differentiate to double 
positive (DP) αβ thymocytes, or to γδ thymocytes. CD4+ CD8+ DP thymocytes will be 
positively selected, and mature to either CD4+ or CD8+ single positive thymocytes. These will 
migrate into the medulla, where they will interact with medullary thymic epithelial cells 
(mTECs) that express tissue-restricted self-antigens under control of the autoimmune 
regulator (Aire). Aire expression in mTECs might be induced by LTIs as well as by early γδ 
T cell precursors. LTi: lymphoid tissue inducer cell. cTEC: cortical thymic epithelial cell. cMes: 
cortical mesenchymal cell. DC: dendritic cell 
Picture modified from Anderson et al, Nat Rev Immunol 2007.  
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After extensive proliferation at the DN1 stage, developing thymocytes migrate from 
the cortico-medullary junction towards the capsule and progress to the DN2 and 
DN3 stage, where final commitment to the T cell lineage is taking place. At these 
stages, expression of the RAG (recombination activating genes) enzymes is induced, 
leading to the rearrangement of the T cell receptor genes. Notable, the early DN3 
stage is also the bifurcation point at which αβ and γδ T cell development diverges. 
 
αβ T CELL DEVELOPMENT 
For αβ T cells, at the DN3 state rearrangement of the β gene locus is occurring. The 
β locus harbors a number of so-called V-, D- and J-gene segments, which will be 
rearranged by RAG-1 and RAG-2 to yield a continuous in-frame VDJ sequence 
coding for the TCR β chain. This β chain will pair with an invariant pre-Tα chain as 
well as CD3 molecules to form the pre-T cell receptor, which seems to be signaling 
in a ligand-independent fashion (Irving et al., 1998). Signaling via the pre-TCR is 
essential for developing αβ thymocytes, and all cells that fail to successfully express 
their β chain will die by apoptosis (Petrie and Zúñiga-Pflücker, 2007). This process is 
usually referred to as β-selection, representing the first developmental checkpoint 
that ensures the functionality of newly formed αβ T cells. 
Following expression of the pre-TCR, a series of profound changes is induced, 
marking the progression to the DN4 stage: VDJ rearrangement at the second allele 
is suspended (allelic exclusion), CD4 and CD8 mRNA is expressed, and cells increase 
their proliferative activity massively (Petrie and Zúñiga-Pflücker, 2007). Concomitant, 
rearrangement of the TCR α locus is started, which comprises only V and J 
segments. Functional α chains will replace the pre-T α chain and together with the β 
chain form a mature T cell receptor. Simultaneous with the mature TCR, CD4 and 
CD8 protein will be expressed on the surface, marking the developmental transition 
from the DN to the double positive (DP) stage (Petrie et al., 1990). 
DP thymocytes reside in the subcapsular zone of the thymus where they extensively 
interact with cortical thymic epithelial cells (cTECs) in order to pass the next 
developmental checkpoint, namely positive selection. At this stage, only DP cells 
binding with a low avidity to self-antigen in the context of self MHC complexes will 
receive a survival signal, while failure to do so will induce apoptosis. Hence, positive 
selection ensures restriction of the mature T cell repertoire to self MHC molecules 
(Zinkernagel et al., 1978). 
Only 5-10% of developing DP thymocytes will survive the positive selection 
checkpoint and will start migrating back to the thymic medulla. Notably, the 
efficiency of this process is higher than random TCR gene rearrangement would 
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suggest, and it was reported recently that germline encoded residues in the αβ TCR 
facilitate recognition of MHC molecules (Scott-Browne et al., 2009).  
During their migration to the medulla, DP thymocytes continue to develop either to 
CD4 or CD8 single positive (SP) αβ T cells (reviewed in (Starr et al., 2003)). 
Obviously this lineage decision depends on the specificity of the TCR: CD4+ T cells 
only recognize MHC class II molecules, while CD8+ T cells only recognize MHC class 
I molecules. The mechanism underlying CD4/CD8 lineage differentiation is still 
incompletely understood, and different models have been proposed (Singer et al., 
2008): first, a stochastic model, in which CD4 and CD8 co-receptors are randomly 
expressed, with only those cells surviving that will still bind MHC molecules. Second, 
an instructive model, in which MHC I restricted TCRs actively repress CD4 expression 
and vice versa (Germain, 2002). However, in the past decade several lines of 
evidence have pointed towards a more complex model, which has been termed 
“coreceptor reversal”: DP thymocytes that have undergone positive selection will 
downregulate CD8 by default, concomitant with upregulation of IL7Rα expression. If 
the ensuing loss of CD8 signaling does not disrupt the TCR signaling, cells will 
progress towards CD4+ T cells. In contrast, if the loss of CD8 interferes with TCR 
signaling, IL7Rα signaling (which is otherwise antagonized by the TCR) will lead to 
silencing of CD4 expression and reintroduce CD8 expression (Bosselut et al., 2003; 
Brugnera et al., 2000; Yu et al., 2006). 
Both CD4 and CD8 single positive thymocytes will migrate further inwards into the 
thymus, leaving the cortical zone and entering the thymic medulla. This migration 
step is dependent on chemokine signaling via the chemokine receptor 7 (CCR7), and 
ensures the next critical selection step during T cell development, which is the 
tolerization of the T cell repertoire to self-antigens (Kurobe et al., 2006). The 
corresponding ligands for CCR7, CCL19 and CCL21 are expressed by medullary 
thymic epithelial cells (mTECs) (Misslitz et al., 2004). 
As mentioned above, the random nature of TCR gene rearrangement generates a 
vast diversity of TCR specificities, which inevitably will also include some self-
antigens. Hence, to avoid potentially fatal destruction of the body’s own organs, self-
reactive T cells need to be purged from the repertoire. Furthermore, a fraction of 
developing CD4+ thymocytes will be diverted towards FoxP3+ regulatory T cells 
(Tregs). These processes are mediated by interactions with mTECs and thymic DCs, 
and will be further discussed in the next chapter in the context of central tolerance. 
Interestingly, recent evidence suggests that not all αβ T cells leave the thymus as 
naïve cells, but that a small fraction of CD4+ T cells is pre-committed towards IL-17 
production (Marks et al., 2009). These cells show preferential usage of certain Vβ-
chains, and similar to FoxP3+ Tregs depend on self-antigen presentation by mTECs 
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for their development (Kim et al., 2011; Marks et al., 2009). However, the specificity 
as well as the precise function of these cells remains unknown, but it is important to 
note that the thymus can be able to select T cells with a pre-defined function 
(Stritesky et al., 2012). 
 
CENTRAL TOLERANCE 
Subsequent to the CD4-CD8 lineage commitment, developing single positive 
thymocytes will spend another 4-5 days in the thymic medulla, before they will leave 
the thymus as mature T cells (Petrie and Zúñiga-Pflücker, 2007). During this time, 
two distinct mechanisms ensure that the mature T cell repertoire remains tolerant 
against self-antigens: negative selection and induction of FoxP3+ Tregs. Both of 
these mechanisms are absolutely essential to prevent fatal autoimmune pathologies 
(Kyewski and Klein, 2006).  
The basis for the seminal theory of negative selection was laid by two independent 
experiments in the late 80s: First, T cells specific for the MHC molecule I-E are 
absent from I-E expressing mice (Kappler et al., 1987), and second, transgenic 
T cells specific for the male antigen H-Y are present in female, but not in male mice 
(Kisielow et al., 1988). Shortly after that, it was shown that the thymic epithelium is 
able to mediate deletional tolerance (Salaün et al., 1990), i.e. the deletion of 
developing thymocytes that recognize self-antigen with a high affinity. 
However, how can developing thymocytes be screened for their reactivity with, for 
example, liver-specific antigens? This remained a puzzle for several years, until it 
was discovered that medullary thymic epithelial cells (mTECs) have the ability to 
express antigens that are usually tissue restricted (Derbinski et al., 2001). This 
phenomenon has been termed “promiscuous gene expression”, and subsequent 
work showed that the transcription factor Aire (autoimmune regulator) is the critical 
mediator of this process (Anderson et al., 2002). By now it has been clearly 
established that Aire-dependent expression of a large number of tissue-restricted 
antigens is essential for immunological tolerance (Anderson et al., 2005), but the 
mechanism underlying the function of Aire remains under scrutiny (Kyewski and 
Klein, 2006; Mathis and Benoist, 2009). 
In addition to mediating negative selection, the thymus is responsible for a second 
central tolerance mechanism, namely the generation of FoxP3+ nTregs. Several lines 
of evidence suggest that at least a fraction of nTregs is selected on the basis of self-
antigen-recognition (Jordan et al., 2001), and that co-stimulation (Tai et al., 2005) 
and cytokine signaling via IL-2 is relevant for this process (Lio and Hsieh, 2008). 
Both thymic DCs as well as mTECs seem to be equally well equipped to induce 
nTregs (Wirnsberger et al., 2009), but it remains unknown which mechanism 
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precisely determines whether a self-reactive thymocyte will undergo clonal deletion 
or nTreg induction. However, it seems that the number of nTregs is limited to a 
small thymic niche (Bautista et al., 2009). 
 
γδ T CELL DEVELOPMENT 
While for αβ T cells their complex development is understood in remarkable detail, 
γδ T cell development proved to be more difficult to study, mostly due to the 
absence of specific markers beside the γδ TCR itself. An early study in the 1990s 
suggested already that selection of the δ chain occurs roughly at the same 
developmental stage as β selection, i.e. the DN3 stage (Passoni et al., 1997). 
However, it was only in 2006 that a novel TCRδ-GFP reporter mouse allowed the 
definitive proof that the γδ and αβ T cell lineage diverge at the DN3 stage of thymic 
development (Prinz et al., 2006). Contrary to αβ T cell development there is no pre-γ 
chain, but rather TCRγ and TCRδ rearrangement occurs simultaneously. It was also 
shown that the progression of γδ thymocytes beyond the DN3 stage to γδ-TCRhigh 
thymocytes is controlled by γδ TCR surface expression, followed by a short 
proliferative burst (Prinz et al., 2006). 
However, while the time-point at which the αβ and γδ T cell lineage diverge has 
been well defined, the underlying molecular mechanism is still very enigmatic. Up to 
date, only one transcription factor that promotes γδ T cell development has been 
defined, namely SOX13 (Melichar et al., 2007), which is a member of the high-
mobility group (HMG) family. Overexpression of Sox13 impaired αβ T cell 
development, while deficiency in Sox13 led to a strongly reduced γδ T cell 
population. Interestingly, a point-mutation in Sox13 was shown to cause the 
complete absence of a very specific γδ T cell population, which are IL-17 
precommitted Vγ4+ γδ T cells (Gray et al., 2013). This finding further emphasized the 
importance of Sox13 for γδ T cell development, but additional cell type-specific 
transcription factors involved in γδ T cell function remain unknown. However, it has 
been postulated that double positive αβ thymocytes influence the development of γδ 
T cell precursors in trans via LTβ-signals, but the consequences of this interaction 
have not been understood in detail yet (Silva-Santos et al., 2005). 
There are several additional features of γδ T cell development that distinguish them 
in a remarkable way from conventional αβ T cells: First, in the ontogeny of all 
vertebrates, γδ T cells mature in the thymus prior to the emergence of the first 
αβ T cells. This suggests that one important contribution of γδ T cells to immunity is 
neonatal protection. Indeed it has been reported that in newborn humans γδ T cell 
are particularly numerous (Gibbons et al., 2009), and that neonatal infection with 
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Cytomegalovirus (CMV) leads to a strong IFN-γ response by an oligoclonal Vγ8+ pool 
of γδ T cells (Vermijlen et al., 2010). 
Second, while the majority of αβ T cells are thought to leave the thymus as naïve 
cells, capable of further differentiation towards various effector programs, for γδ 
T cells thymic pre-programming to a certain effector lineage has been reported. 
Based on studies of γδ T cells recognizing the non-classical MHC I molecules T10 and 
T22 (Shin et al., 2005), it was shown that those γδ T cells that have encountered 
self-antigen in the thymus will become hard-wired towards an IFN-γ producing 
phenotype, whereas antigen-naïve γδ T cells will turn into IL-17 producers (Jensen 
et al., 2008). This report was substantiated by the ensuing discovery of a surface 
marker to distinguish IFN-γ producing from IL-17 producing γδ T cells, namely CD27 
(Ribot et al., 2009). Also, certain TCR specificities segregate with the ability to 
produce a particular effector cytokine, for example Vγ4+ and Vγ6+ γδ T cells mainly 
comprise IL-17 producing cells. However, the functional implication of this thymic 
commitment is not yet fully understood. Also, it remains unknown whether γδ T cells 
require thymic positive selection or not. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Development of different γδ  T cell subsets in ontogeny.  
In contrast to αβ T cells, the development of certain γδ T cell populations coincides with 
hard-wired functional properties and homing receptors. Dendritic epidermal T cells (DETCs) 
are the very first T cells to develop in the thymus, and also IL-17 producing γδ T cells (mostly 
of the Vγ4+ and Vγ6+ subclasses) develop only within a certain neonatal window. However, 
the adult thymus continues to produce γδ T cells (at least in the murine system), whose 
functional properties remain to be fully characterized. IEL: intraepithelial lymphocyte. NKT: 
natural killer T cell. 
Graph modified from Prinz et al., Eur. J. Immunol 2013.  
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Third, certain clonal γδ populations develop in embryonic waves and directly 
populate their respective target organ, with Vγ5+ DETCs being the first mature T cell 
emerging from the murine thymus (Havran and Allison, 1988).  
Further complexity was added by a recent report in that the development of CD27- 
IL-17 producing γδ T cells is also restricted to a certain time window during 
embryogenesis (Haas et al., 2012). This suggests that the thymic microenvironment 
at a given embryonic stage provides specific cues to developing T cell precursors to 
steer them towards a particular lineage. However, what processes ensure that 
despite the vast diversity of theoretical γδ TCR specificities (Carding and Egan, 2002) 
only few oligoclonal γδ populations develop, remains enigmatic. 
In a recent effort by the Immunological Genome Project Consortium, developing 
murine γδ thymocytes subsets were separated based upon their expression of 
different TCRγ chains and subjected to whole-genome transcriptome analysis. 
Surprisingly, this study revealed that the transcriptional program of γδ thymocytes of 
different specificity diverge from each other as far as for example from CD8+ αβ 
T cells (Narayan et al., 2012). This emphasizes the notion that thymic pre-
commitment is indeed an essential factor in the determination of γδ T cell function, 
and that the resulting transcriptional networks are vastly different. 
 
DETC DEVELOPMENT 
Though dendritic epidermal T cells are only found in the epidermis of mice, these 
cells due to their identification via the canonical Vγ5Vδ1 TCR provide a unique model 
system to study general signaling pathways involved during early T cell development 
as well as the typical properties of intraepithelial lymphocytes (IELs). 
As discussed above, Vγ5+Vδ1+ DETCs are the very first T cells to mature in the 
embryonic thymus (Havran and Allison, 1988) and populate the epidermis, where 
they remain as a radio-resistant population. The almost monoclonal TCR repertoire 
of DETCs strongly pointed towards some kind of positive selection mechanism, and 
indeed in 2008 it was shown that a novel immunoglobulin-like protein termed Skint-
1 (Selection and upkeep of intraepithelial T cells 1) is the essential selecting agent 
(Boyden et al., 2008; Lewis et al., 2006). Skint-1 seems to be specifically expressed 
by mTECs in the thymus and keratinocytes in the epidermis, but evidence suggests 
that this molecule does not directly interact with the γδ TCR (Barbee et al., 2011). 
Notably, the molecular mechanism induced by Skint-1 engagement involves signals 
via NFκB and NFAT (nuclear factor of activated T cells) and seems to be a conserved 
pathway also for developing γδ T cells in the adult thymus (Turchinovich and 
Hayday, 2011).  
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Unexpectedly, another important role has been attributed to these early γδ T cell 
precursors by a very recent report showing that Vγ5+ thymocytes can induce Aire 
expression in developing mTECs. This interaction involves signaling via the RANK-
RANKL (Receptor Activator of NF-κB Ligand) axis (Roberts et al., 2012). However, it 
remains unknown whether a similar mechanism is in place during human TEC 
development. 
 
After this overview on the mechanism underlying αβ and γδ T cell development and 
the generation of tolerance to self-antigens, we switch now to one of the most 
prominent autoimmune pathologies, which is multiple sclerosis (MS). After that, we 
will discuss one of the most important signaling pathways in immune cells, NFκB 
signaling, and its role in the animal model of MS, which is experimental autoimmune 
encephalomyelitis (EAE). Furthermore, we will outline the known and potential roles 
of NFκB in the pathogenesis of EAE, but also in the development of γδ T cells and 
the induction of central tolerance, which is the basis for the data presented within 
this thesis. 
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MULTIPLE SCLEROSIS 
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system 
(CNS) that leads to demyelination of axons and ultimately neurological impairment. 
The disease is particularly prevalent in Europe and Northern America, and affects 
approximately twice as many women as men, starting typically at the age between 
20 and 40. The most common form of MS is relapsing-remitting MS (RR-MS), which 
is characterized by sequential clinical episodes that usually resolve themselves over 
time. RR-MS typically progresses to secondary-progressive MS (SP-MS), during 
which brain atrophy can be observed (Sospedra and Martin, 2005). 
The first description of MS dates back to 1868 by Jean-Martin Charcot, and these 
days the disease is usually diagnosed by the presence of lesions and plaques in the 
white matter of the CNS. MS has been considered to be a T cell mediated 
autoimmune disease, and while the exact etiology as well as the effector mechanism 
damaging the myelin are still unknown, a combination of environmental risk factors 
in conjunction with genetic predisposition is held responsible for the development of 
the disease (Dyment et al., 2004). 
Indeed, in 2011 a major genome-wide association study has corroborated the 
contribution of the immune system to MS pathogenesis: the main risk genes found 
in this study are involved in cell-mediated immune responses, such as MHC class II 
molecules, IL-2, IL-12, IL7-receptor and members of the STAT family (Sawcer et al., 
2011). In fact the largest risk factors for development of MS are two genes of the 
HLA-DR15 haplotype (DRB1*1501 and DRB5*0101) (Hillert and Olerup, 1993; Jersild 
et al., 1973). 
Inherently, it is almost impossible to study the cellular events underlying disease 
development of MS in humans, and hence most of the research in the context of MS 
relies on animal models. The most prominent among those is experimental 
autoimmune encephalomyelitis (EAE). 
 
EXPERIMENTAL AUTOIMMUNE ENCEPHALOYMELITIS (EAE) 
EAE has been described for the first time more than 50 years ago (Olitsky and 
Yager, 1949), and ever since then has been used as an animal model to study 
autoimmune neuroinflammation (McFarland and Martin, 2007). It can be induced by 
subcutaneous immunization of mice with myelin proteins or peptides in conjunction 
with complete Freund´s adjuvant (CFA), which induces a myelin-reactive T cell 
response. The most common antigens used are myelin basic protein (MBP), 
proteolipid protein (PLP) or myelin oligodendrocyte glycoprotein (MOG). 
Most basic research has been performed in murine models, due to the good 
availability of inbred mouse strains and targeted mutations. In C57BL/6 mice, the 
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disease symptoms start around day 10-12 post immunization with an ascending 
paralysis, which will first affect the tail, then the hind legs and will proceed towards 
the front limbs. Correspondingly, inflammation during EAE is mostly seen in the 
spinal cord and the cerebellum. 
Mechanistically, the pathogenesis of EAE has been attributed to auto-reactive TH1 
cells for decades. However, this notion was challenged by the fact that both in mice 
and men neutralization of the signature cytokine of TH1 cells, IFN-γ, resulted in 
exacerbation of EAE and MS symptoms, respectively (Billiau et al., 1988; Panitch et 
al., 1987a; 1987b) (Chu et al., 2000). Together with the apparent EAE resistance 
caused by neutralization of the TH1 polarizing cytokine IL-12 (Leonard et al.), this 
finding has puzzled immunologists for a while.  
This mystery was unraveled by a series of reports in 2003, in which it was shown 
that the newly discovered cytokine IL-23, which shares the p40 subunit with IL-12, 
is the critical factor for development of EAE (Becher et al., 2002; Cua et al., 2003). 
After the discovery of IL-23 and its link to the polarization of TH17 cells (Langrish, 
2005), a novel scapegoat for autoimmune pathologies was found, namely IL-17. 
However, while TH17 cells have been implicated in a variety of autoimmune 
diseases, including MS (Cua et al., 2003), arthritis (Murphy et al., 2003) and 
Crohn´s disease (Annunziato et al., 2007), the importance of IL-17 itself in the 
context of EAE can be questioned (Haak et al., 2008). Indeed, recent reports 
suggested that pathogenic CD4+ T cells rather show a “multifunctional” state (Hirota 
et al., 2011), and the current dogma on T helper cell differentiation is changing 
towards a more “plastic” view (Bluestone et al., 2009). Most importantly, T cell 
dependent production of granulocyte-macrophage colony stimulating factor (GM-
CSF) has been shown to be a critical IL-23 induced effector cytokine during EAE 
(Codarri et al., 2011; El-Behi et al., 2011). 
Taken together, the development of experimental neuro-inflammation seems to be 
strictly dependent on IL-23, but the exact downstream effector molecules are still a 
matter of debate, as well as the T cell intrinsic effector mechanisms contributing to 
the disease. Also, while a lot of research has been devoted to T cell derived effector 
cytokines, not so much is known about signaling pathways that could modulate 
disease induction or progression. 
 
THE ROLE OF DCS IN EAE 
While T cells without doubt are critical effector cells during EAE, the initial shaping of 
an adaptive immune response is primarily dependent on the function of DCs 
(Banchereau and Steinman, 1998). Since their first discovery (Steinman and Cohn, 
1973), DCs have been categorized into many different subclasses (reviewed in 
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(Merad et al., 2013)), the two most important being plasmacytoid DCs (pDCs) and 
classical DCs (cDCs). cDCs in turn, can again be subdivided into CD11b+ DCs and 
CD8+ DCs, which in non-lymphoid tissues do not express CD8 but rather CD103 
(Ginhoux et al., 2009). CD8+ DCs have been shown to be very efficient in cross-
presentation, which is the ability to present phagocytosed antigen in the context of 
MHC class I molecules (reviewed in (Joffre et al., 2012)). 
Several lines of evidence have implicated DCs in the induction and progression of 
autoimmune diseases, including Type-1 diabetes (Turley et al., 2003), psoriatic skin 
inflammation (Wohn et al., 2013) and EAE (reviewed in (Ganguly et al., 2013)).  
 
Beside the presentation of self-antigen, the most obvious role of DCs during 
autoimmunity might be the production of the T cell polarizing cytokines IL-12, IL-23 
and also IL-6, making DCs decisive players during initial T cell activation (Oppmann 
et al., 2000). However, the mechanism governing which of these cytokines will be 
produced remains incompletely understood. In the context of EAE, it has been 
Figure 4: Proposed roles of DCs in autoreactive T cell responses. 
There is evidence that during autoimmune reactions, DCs can either have anti-inflammatory 
(left panel) or pro-inflammatory roles (right panel). In the context of EAE, presentation of 
myelin antigens in the context of pro-inflammatory stimuli such as IL-23 or IL-12 is the most 
heralded function of DCs. Particularly secretion of IL-23 might be an essential step in the 
generation of pathogenic T cells, but it remains unclear what factors determine IL-23 
production in DCs. TGFβ: transforming growth factor beta. TCR: T cell receptor. MHC: major 
histocompatibility complex. CTL: cytotoxic T lymphocytes. IL: Interleukin. PD1: programmed 
death 1. T1D: Type 1 diabetes. SLE: Systemic lupus erythematosus. EAE: Experimental 
autoimmune encephalomyelitis. 
Graph modified from Ganguly et al, Nat Rev Immunol 2013.  
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shown that DCs are the only non-redundant cells for the activation of autoreactive 
T cells (Greter et al., 2005). Also, there has been some evidence that CD11b+ DCs in 
the CNS are involved in epitope spreading and the production of proinflammatory 
signals driving TH17 cells (Bailey et al., 2007), and that CNS-infiltrating myeloid cells 
are the target of GM-CSF (Codarri et al., 2011). Furthermore, the induction of EAE 
upon subcutaneous immunization seems to depend on dermal CD103+ DCs (King et 
al., 2010), which pick up the antigen and migrate to the skin draining lymph node, 
where they prime the T cell response. However, there are conflicting results as to 
whether these conclusions can be reproduced in a genetic model that lacks dermal 
CD103+ DCs (Edelson et al., 2011). 
In summary, DCs are without doubt essential cells contributing both to the induction 
and progression of EAE, but it is only recently that DC-specific signaling pathways 
involved become unraveled. One example for this is the fact that signaling via the 
kinase p38α in a DC intrinsic manner is essential for the development of EAE (Huang 
et al., 2012). 
 
NFκB SIGNALING 
Every eukaryotic cell utilizes a complex network of intracellular signaling cascades, 
which convey signals that are being sensed by cell surface receptors either into the 
cytoplasm or into the nucleus, thus changing the transcriptional profile of the cell. 
One of the most prominent signaling pathways is the nuclear factor kappa B (NFκB) 
pathway, which is utilized by almost all mammalian cell types, but has its most 
important function in cells of the immune system. 
NFκB was discovered in the mid 80s as a positive regulator of kappa light chain 
expression in B cells (Sen and Baltimore, 1986). By now it is clear that NFκB 
comprises a family of transcription factors, which play diverse roles in different cells 
of the innate and adaptive immune system. In mammals, five different family 
members have been identified: RelA (p65), RelB, c-Rel, NF-κB1 (p50) and NF-κB2 
(p52) (Li and Verma, 2002). Importantly, these monomeric proteins need to 
dimerize to form functional NFκB. Various hetero- and homodimers have been 
identified, explaining the diverse transcriptional changes induced by NFκB signaling.  
All monomers share a structurally conserved amino-terminal Rel-homology domain 
(RHD), in which the dimerization-, the nuclear localization- and the DNA-binding 
motifs are located. For RelA, RelB and c-Rel the C-terminus contains a 
transactivation domain. In resting cells, NFκBs are kept inactive by association with 
cytoplasmic inhibitory proteins, namely inhibitor of NFκB-α (IκBα), IκBβ and IκBε. 
Furthermore, both NF-κB1 and NF-κB2 are present as larger precursor proteins, 
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namely p105 and p100, which need to be proteolytically processed for their 
activation. 
Activation of NFκB occurs via many different receptors, but can be divided into two 
signaling pathways, which have been termed canonical (classical) and non-canonical 
(alternative) pathway. These pathways integrate different stimuli and will be 
discussed in further detail below, with the main focus set on the alternative 
pathway. 
 
CANONICAL NFκB SIGNALING 
Among the main activators of the classical NFκB signaling pathway are members of 
the tumor-necrosis-factor receptor (TNFR) family, IL-1 receptor and members of the 
toll-like receptor (TLR) family. Downstream of the corresponding receptors are 
various adaptors, including mainly the TNFR-associated factor (TRAF) proteins. 
Furthermore, the classical pathway can also be activated via signals from the TCR 
and BCR, respectively (Su et al., 2002; Sun et al., 2000). 
The central protein complex in canonical NFκB signaling is the IKK-complex (also 
called NEMO), which consists of the two catalytic subunits IKK-α and IKK-β as well 
as the regulatory subunit IKK-γ. Upon activation, the catalytic subunits 
phosphorylate IκB-α, which subsequently gets ubiquitylated and degraded, thus 
releasing the p50-RelA (NFκB1) and p50-c-Rel dimer for translocation into the 
nucleus. Notably, one of the earliest transcriptional targets of NFκB1 is the gene 
encoding IκB-α, thus forming a negative feedback loop that prevents irreversible 
activation of NFκB1 (Sun et al., 1993). The first insights into the role of NFκB1 in 
vivo have been obtained in the mid 90s, when p50 knockout mice were generated 
(Sha et al., 1995). These animals developed normally, but showed multiple immune 
defects, in particular impaired B cell responses. Also, control of bacterial infections 
such as Streptococcus pneumonia was impaired, emphasizing the importance of 
canonical NFκB activation for initiation of adaptive immunity. Furthermore, NFκB1 
knockout animals have been reported to show impaired CD4 T cell responses, 
leading to reduced clearance of Leishmania major infections (Artis et al., 2003). 
 
NON-CANONICAL NFκB SIGNALING 
In 1997, a novel protein kinase was cloned and characterized as a TRAF-2 
dependent, positive regulator of NFκB activity (Malinin et al., 1997). This protein 
was termed NFκB inducing kinase (NIK), also known as Map3k14.  
Shortly after that, the so-called alymphoplasia (aly) mutation (Miyawaki et al., 1994) 
was mapped to the gene locus coding for NIK, suggesting that the phenotype of 
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NIKaly/aly mice is due to the absence of NIK signaling (Shinkura et al., 1999). The 
autosomal recessive aly mutation, that arose spontaneously in a breeding facility in 
1986, causes very diverse immunological phenotypes: complete absence of lymph 
nodes and Peyer’s Patches, loss of the cortico-medullary border in the thymus, an 
inability to produce IgA antibodies and a disorganized splenic structure with a loss of 
B cell follicles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Pathways for induction of NFκB. 
The NFκB family of transcription factors is activated by many different receptors, but can be 
broadly categorized into two signaling pathways: canonical (or classical) NFκB signaling and 
alternative (or non-canonical) signaling. However, there is evidence for crosstalk between 
these two pathways.  
In the canonical pathway the IKK-α, IKK-β, IKK-γ complex is the central signal integrator. For 
non-canonical signaling, both IKK-a and the NFκB-inducing kinase (NIK) are essential. Upon 
activation via upstream TRAFs, NIK protein will get stabilized, phosphorylate IKK-a, which in 
turn will cause the partial proteolytic processing of p100 to p52. P52 will form a heterodimer 
with Rel-B and translocate into the nucleus and induce transcription of pro-inflammatory 
target genes. 
BCR: B cell receptor. TCR: T cell receptor. TNFR: Tumor necrosis family receptor. TLR: Toll 
like receptor. NIK: NFκB inducing kinase. 
Graph modified from Siebenlist et al, Nat Rev Immunol 2005. 
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Final proof that these defects are indeed due to abrogated NIK signaling came from 
the generation of targeted NIK knockout mice, that exactly phenocopied NIKaly/aly 
mice (Yin et al., 2001). Subsequently, the importance of NIK as a unique player in 
NFκB activation was emphasized by a report in 2001, showing that NIK in 
conjunction with IKK-α can lead to NFκB activation in an IKK-β and IKK-γ 
independent fashion (Senftleben et al., 2001), thus disconnecting this signaling 
pathway from the classical IKK(NEMO)-complex. As a result, this novel pathway was 
termed alternative, or non-canonical NFκB signaling.  
The current knowledge on this signaling pathway suggests the following mechanism 
(reviewed in (Sun, 2010)): in the steady state, NIK is constantly ubiquitinylated and 
degraded via a TRAF-2/TRAF-3 dependent mechanism (He et al., 2006). Upon 
surface receptor stimulation, these TRAFs get themselves degraded, leading to the 
release and accumulation of NIK (Liao et al., 2004). NIK in turn will phosphorylate 
IKK-α, which will cause the partial proteolytic processing of p100 to p52 (Ling et al., 
1998) (Xiao et al., 2001). p52 will form a heterodimer preferentially with Rel-B, 
translocate to the nucleus and start NFκB2 dependent gene expression. A negative 
feedback loop via IKK-α mediated NIK phosphorylation exists (Razani et al., 2010). 
Of note, signaling via NIK requires de novo protein synthesis to allow for 
accumulation of functional NIK protein (Liao et al., 2004), a feature that 
distinguishes this pathway from classical NFκB activation that usually proceeds very 
rapidly without the need for additional protein synthesis.  
 
THE FUNCTION OF NIK SIGNALING IN THE IMMUNE SYSTEM 
It has been known for some time that NIK conveys signals from the LT-β receptor 
(Matsushima et al., 2001) and from the B cell activating factor (BAFF) receptor 
(Claudio et al., 2002). Hence, non-canonical NFκB signaling has been mainly 
implicated in lymphoid organogenesis, which is dependent on LT-β (Fütterer et al., 
1998), and in B cell maturation and survival (Claudio et al., 2002). 
Within the past decade it became evident that signaling via NIK is triggered by 
additional stimuli, most prominently CD40 (Garceau et al., 2000), Receptor activator 
of NFκB (RANK) (Darnay et al., 1999), CD28 (Sánchez-Valdepeñas et al., 2006) and 
CD70 (Ramakrishnan et al., 2004). In addition, some reports challenged the notion 
that NIK activates only the non-canonical NFκB pathway (Ramakrishnan et al., 2004) 
(Zarnegar et al., 2008), leaving the open question under which stimuli non-canonical 
and classical NFκB activation overlap. 
However, irrespective of the complex interplay between canonical and alternative 
NFκB activation, the variety of signals relayed via NIK makes it a key modulator of 
immune function. Indeed, NIKaly/aly mice have been used for some time as a model 
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for immunodeficiency, since these animals are unable to mount proper antibody 
responses, have impaired immunity towards viruses (Karrer et al., 1997) and show a 
poor ability to reject skin grafts (Lakkis et al., 2000). Initially, this immunodeficiency 
has been mainly attributed to the absence of secondary lymphoid tissues (SLTs), but 
as was shown by our lab, SLTs are not a prerequisite for the induction of cell-
mediated immunity (CMI) (Greter et al., 2009).  
As a result, it became increasingly evident, that beside the lack of SLTs, abrogation 
of NIK signaling causes intrinsic defects in multiple immune cell types. Indeed, it has 
been suggested that NIK is critical for full activation of CD4+ T cells and their ability 
to secrete IL-2 (Ishimaru et al., 2006; Matsumoto et al., 2002). In the study by 
Ishimaru et al., NIKaly/aly T cells were separated into naïve and memory populations 
and it was concluded, that naïve NIKaly/aly T cells are in fact hyperresponsive, but 
suppressed by the NIKaly/aly memory T cell pool via an IL-2 receptor mediated 
mechanism. 
Subsequent to these studies, work from our lab and others showed that both NIK-/- 
and NIKaly/aly mice are resistant towards the development of EAE (Jin et al., 2009; 
Greter et al., 2009). Also, we could observe that NIK-/- T cells (in addition to their 
known impairment to produce IL-2) have a reduced ability to secrete several pro-
inflammatory cytokines, including IFN-γ, IL-17 and GM-CSF (Hofmann et al., 2011). 
Of note, neither in the study by Jin et al., nor in our own work the same proliferative 
impairments of NIK-deficient T cells were observed that have been reported by 
Ishimaru et al. previously. 
 
 
Figure 6: Normal T cell function and susceptibility to EAE is dependent on NIK 
signaling in DCs, but not in T cells. 
(A) Lethally irradiated Rag1-/- mice were reconstituted with bone marrow from NIKaly/aly-2D2, 
NIKaly/aly-2D2 or a 4:1 mixture of Rag1-/- and NIKaly/aly-2D2 donors. Six weeks after 
reconstitution animals were immunized with MOG/CFA and monitored for clinical EAE 
symptoms. (B) Lethally irradiated wild-type mice were reconstituted with bone marrow from 
DCNIK-NIK-/-, DCNIK-NIK-/+ and NIK-/- donors, and after reconstitution immunized with 
MOG/CFA. Graphs adapted from Hofmann, Mair et al, J. Exp Med 2011. 
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However, despite the above mentioned reports that suggested T cell intrinsic defects 
to be responsible for the EAE resistance of NIK-/- mice (Jin et al., 2009), several 
experiments performed in our lab indicate that the failure of NIK-/- T cells to initiate 
cell-mediated immunity and clinical EAE symptoms is rather due to a DC intrinsic 
defect. First, we have generated a system in which the majority of accessory cells 
(including DCs) are NIK sufficient, while all T cells are NIK-deficient. To do so, 
lethally irraditiated Rag1-/- recipients were reconstituted with a 4:1 mixture of Rag1-/- 
and 2D2 NIKaly/aly bone marrow. 2D2 is the acronym for a TCR transgene encoding a 
TCR specific for the myelin oligogendrocyte glycoprotein (MOG) (Bettelli et al., 
2003). In the resulting chimeras, the majority of the accessory cells will be derived 
from the Rag1-/- bone marrow, which is NIK sufficient. In contrast, all T cells will be 
derived from the 2D2 NIKaly/aly bone marrow. In these mixed bone marrow chimeras, 
normal T cell function is restored (Hofmann et al., 2011). Also, these animals show 
normal susceptibility to EAE (Figure 6a). 
Second, we used a transgenic system in which an inducible NIK allele was 
specifically expressed in DCs, while all other cells remain NIK-deficient. For this, we 
used a knockin of NIK into the ubiquitously expressed Rosa26 locus (Sasaki et al., 
2008) that was preceded by a LoxP-flanked Stop codon. Upon breeding these 
animals onto a NIK-/- background and further crossing to CD11c-Cre animals, the 
Stop cassette is excised in CD11c+ cells and thus will induce expression of wild-type 
NIK only in DCs. The resulting DCNIK-NIK-/- mice showed normal susceptibility to EAE, 
and cytokine production of NIK-/- T cells was restored to wild-type levels (Figure 6b) 
(Hofmann et al., 2011). 
Third, we performed experiments in which we adoptively transferred 2D2 T cells into 
Rag-/- NIK-/- recipients, followed by immunization with MOG/CFA. In this situation, 
where T cells do not have a genetic defect, but only the APCs including DCs are NIK 
deficient, no clinical signs of EAE could be observed (Romy Höppli, unpublished 
data). 
All of these experiments strongly argue for an essential DC intrinsic role of NIK 
during the induction of EAE. In line with this, NFκB2 has been implicated already 
before in the function of DCs, for example for their ability to cross-present antigens 
(Lind et al., 2008). Also, LTβ-receptor signaling was shown to regulate the pool size 
of CD8- splenic DCs (Kabashima et al., 2005). Furthermore, c-Rel was suggested to 
be involved in TLR-mediated induction of IL-23p19 (Carmody et al., 2007), which is 
particularly interesting in the context of autoimmune disease. 
In summary, it is evident from the available literature that signaling via NIK has 
critical roles in different immune cell types. Nevertheless, it is not entirely clear yet 
which cell type depends on the function of NIK for the induction of cell-mediated 
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immunity, and particularly the role of NIK signaling in different DC populations has 
not been fully characterized yet. 
 
NIK AND THE ESTABLISHMENT OF CENTRAL TOLERANCE 
In addition to these above-mentioned defects in T cells and DCs, a large body of 
evidence implicates signaling via NIK in the establishment of central tolerance. 
Already shortly after the initial description of NIKaly/aly mice (Miyawaki et al., 1994) it 
was reported that despite their generalized immunodeficiency, these animals show 
chronic inflammatory infiltrates in some exocrine organs such as the salivary gland 
(Tsubata et al., 1996), suggesting T cell autoreactivity. 
As discussed above, central tolerance to a large part is dependent on the 
promiscuous gene expression of peripheral self-antigens by medullary thymic 
epithelial cells (mTECs). This process requires expression of Aire (Kyewski and Klein, 
2006), and there is still an intense debate about several NIK-dependent signaling 
pathways that can regulate Aire expression (Mathis and Benoist, 2009). 
Initially, it was reported that thymi isolated from LTβ-receptor deficient mice have 
impaired expression of Aire, causing a mild autoimmune syndrome (Chin et al., 
2003; Zhu et al., 2010). However, several subsequent reports questioned this notion 
(Boehm et al., 2003; Martins et al., 2008; Venanzi et al., 2007). The current view is 
that the LT pathway does not directly regulate expression of Aire on a per cell basis, 
but rather is important for the proper spatial organization of mTECs in the thymic 
medulla (Mathis and Benoist, 2009). 
Instead, it seems that another receptor that is signaling via NIK is essential for the 
development of Aire+ mTECs, namely the Receptor Activator of NF-κB (RANK). 
Signals from RANK ligand (RANKL) derived either from lymphoid tissues inducer cells 
early in development or from positively selected thymocytes later in ontogeny seem 
to be essential for the formation of Aire-expressing mTECs (Akiyama et al., 2008; 
Hikosaka et al., 2008; Irla et al., 2008; Rossi et al., 2007). As mentioned in previous 
chapters, embryonic Vγ5+ γδ T cell precursors might also participate in this process 
(Roberts et al., 2012). 
In summary, several upstream molecules of NIK have been implicated in the 
formation of a mature thymic mTEC population capable of inducing central 
tolerance. This would explain why NIKaly/aly and NIK-/- animals in several experimental 
settings were reported to develop late-onset autoimmune disease (Tsubata et al., 
1996) (Kajiura et al., 2004). But numerous open questions remain, among them 
how in detail NIK signaling influences the maturation of the mTEC pool, which 
function NIK has in thymic DCs and particularly how the T cell selection process is 
influenced as a result. While thymic DCs are relevant contributors to negative 
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selection (Gallegos, 2004), data generated in our lab suggest that they might 
participate in a “licensing” process that allows developing T cells to reach their full 
effector potential (Hofmann et al., 2011). This function of thymic DCs seems to 
depend on NIK and definitely requires further experimentation to reveal the 
underlying mechanism and relevance for T cell function. 
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SPECIFIC AIMS 
 
 
As discussed above, the available data indicate that signaling events via the NFκB 
inducing kinase (NIK) play distinct roles in various cell types of the immune system, 
both in the context of central tolerance as well as immune effector function. Due to 
these manifold phenotypes caused by complete deletion of NIK, the available models 
make it very tricky (if not impossible) to precisely assess the role of NIK signaling in 
individual cell types without confounding bystander effects. 
Hence, a conditional mouse model is needed to unambiguously clarify the relevance 
of NIK. This novel tool would clearly broaden our understanding of non-canonical 
NFκB activation not only in the context of DC and T cell function, but also with 
regard to the development of lymphoid tissues as well as central tolerance 
mechanisms. 
 
Within the scope of this thesis I will focus on the following research areas: 
 
- The development and function of lymphoid and tissue-resident γδ T cell subsets 
in the absence of NIK signaling, using NIK-deficient mice as a model 
- The generation and characterization of a novel conditional mouse model 
(NIKflox/flox) that allows tissue-specific deletion of NIK 
- Characterizing the effects of DC-specific deletion of NIK on the steady state pool 
of DCs and the development of cell-mediated immunity, using EAE as a model 
 
In the appendix I will discuss the potential involvement of a recently characterized 
novel immune cell type, namely innate lymphoid cells (ILCs), during the 
pathogenesis of EAE.  
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RESULTS 
 
NIK SIGNALING AND γδ  T CELL FUNCTION 
DISTURBED DETC COMPARTMENT IN THE ABSENCE OF NIK 
As discussed in the introduction, dendritic epidermal T cells (DETCs) expressing the 
clonotypic Vγ5Vδ1 TCR are the prototype of a highly specialized subset of γδ T cells 
that only seeds the murine epidermis. Based on previous work from others that has 
implicated NFκB family members in the development of unconventional iNKT cells 
(Sivakumar et al., 2003) and the work from our own lab (Hofmann et al., 2011), we 
speculated that NIK signaling might be necessary for the function of unconventional 
γδ T cell subsets, of which DETCs are a prime example. 
Flow cytometric analysis of the cellular composition of the epidermis in both adult 
NIK-/- and NIKaly/aly mice revealed striking differences within the DETC compartment. 
While in control animals, as expected almost 100 % of the CD45+ CD11b- cells in the 
epidermis constitute CD3hi TCRγδhi Vγ5+ DETCs, in NIK-/- mice only 30-60% of the 
cells expressed the Vγ5 TCR (Figure 7b). In addition, an obscure population of CD3int 
TCRγδint was consistently present in NIK-/- mice. To evaluate whether the Vγ5- cells in 
NIK-/- animals expressed alternative TCRγ chains, we stained for the Vγ4 and Vγ1.1 
chains, which were not detectable (Figure 7c). We also analyzed expression of the 
Vγ6 chain using the 17D1 clone (Roark et al., 2004), but could not detect any 
infiltrating Vγ6+ T cells (data not shown). Furthermore, the Vγ5- cells in NIK-/- 
animals did not express any TCR β chains (data not shown). 
Morphologically, DETCs show a typical dendritic shape very similar to Langerhans 
cells (Boismenu and Havran, 1994), which has been reported to change upon 
activation for example by stress ligands (Strid et al., 2008). However, microscopic 
analysis of epidermal sheets to assess the morphology of Langerhans cells and 
DETCs in NIKaly/aly animals and littermate controls showed no overt differences both 
in shape and size (Figure 7d). Also, the density of DETCs in the epidermis appeared 
similar in NIKaly/aly mice and controls. 
Taken together, these findings suggest that in the absence of NIK signaling, an 
additional Vγ5- subset of γδ T cells with similar morphologic properties, but unknown 
TCRγ chain expression populates the epidermis. Additionally, a TCRγδint population of 
unknown origin infiltrates the epidermis of NIK-/- animals. 
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Figure 7: Disturbed steady-state DETC compartment in adult NIK-/- animals. 
(A) Gating strategy used for flow cytometric analysis of the epidermis: doublets were excluded 
by gating on FSC-A vs FSC-H, dead cells were excluded using an amino-reactive live/dead 
reagent. CD45+ CD11b- cells were gated for downstream analysis (similar gating strategies 
excluding doublets and dead cells were used for all flow cytometric experiments). (B) Vγ5 
expression within the epidermal γδ T cell compartment in heterozygous controls (left plots) and 
NIK-/- animals (right plots) (C) Quantification of total γδ T cells as well as Vγ5+, Vγ4+ and Vγ1.1+ 
γδ T cells in the epidermis of NIKaly/aly mice (D) Epidermal sheets were prepared from NIKaly/wt 
(left plot) and NIKaly/aly ears (right plot) and stained with anti-CD3 (red) to mark DETCs and 
MHC class II (green) for Langerhans cells. 
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THYMIC DETC DEVELOPMENT IS BLOCKED IN NIK-/- MICE 
Vγ5+ DETCs (together with Vγ6+ γδ T cells) are the very first T cells to develop in the 
embryonic thymus during ontogeny and populate the epidermis already prior to birth 
(Carding and Egan, 2002; Havran and Allison, 1988). In order to determine whether 
the observed abnormalities in the adult DETC compartment of NIK-/- mice are due to 
a developmental defect, we analyzed the epidermis of day 19 embryos. 
Surprisingly, we found an almost complete absence of γδ T cells in the epidermis of 
NIK-/- animals, while NIK+/- controls had already a sizable fraction of DETCs, which 
all expressed the canonical Vγ5 chain (Figure 8a). Within the few γδ T cells found in 
NIK-/- mice, only around 50% expressed the Vγ5 chain, similar to the steady state 
situation in adult animals (Figure 8b). 
 
 
Based on this paucity of γδ T cells in the embryonic epidermis, we asked whether 
DETC precursors could be found in the thymus at normal numbers. Indeed, when 
analyzing the thymi of day 19 embryos, both total γδ T cells as well as Vγ5+ DETC 
precursors were found in comparable numbers in NIK-/- and NIK+/- animals, albeit 
the total γδ compartment appeared to be slightly reduced in NIK-/- thymi (Figure 9a 
and b). Given the presence of Vγ5+ thymic precursors, but the complete absence of 
mature DETCs in the epidermis, we wanted to assess whether these cells were 
blocked in their development. Several markers have been associated with the 
Figure 8: DETCs are absent from the epidermis of embryonic NIK-/- animals. 
(A) Flow cytometric analysis of embryonic epidermal sheets on day 19 post conception, 
pregated on live CD45+ CD11b- singlets. Upper row depicts heterozygous controls, lower panel 
NIK-/- embryos. (B) Percentage of total γδ T cells (left) as well as Vγ5+ cells in NIK+/- and NIK-/- 
embryonic epidermis. 
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Figure 9: Thymic Vγ5+ DETC precursors seem to be blocked during embryonic 
development.  
(A) Flow cytometric analysis of embryonic thymi isolated on day 19 post conception, 
pregated on live CD45+ CD4- singlets. Upper row depicts heterozygous controls, lower row 
NIK-/- animals. (B) Percentage of total γδ T cells (left) as well as Vγ5+ cells in NIK+/- and NIK-
/- embryonic thymi. (C) Phenotypic analysis of embryonic Vγ5+ thymocytes for expression of 
CD45RB, CD122, CD24 (HSA) and CD62L. Red histograms shows NIK-/- cells, grey shaded 
histograms show NIK+/- cells. (D) Quantification of CD45RB+ and CD122+ cells within the 
Vγ5+ compartment in frequency of parent (left two plots) and median fluorescence intensity 
(MFI) of CD24 and CD62L on Vγ5+ thymocytes (right two plots). 
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developmental progression of thymic DETC precursors, among them CD24 (also 
known as heat stable antigen), CD45RB, CD122 and CD62L (Leclercq et al., 1993) 
(Lewis et al., 2006). Under normal conditions, during their thymic residency from 
embryonic day 15 till day 19, DETC precursors will upregulate expression of CD45RB 
and CD122, while CD24 and CD62L levels will be downregulated. 
In NIK-/- mice, thymic Vγ5+ cells analyzed on embryonic day 19 failed to upregulate 
CD45RB and CD122, and also showed reduced downregulation of CD24 and CD62L 
(Figure 9c and d). The same phenotype was observed when analyzing day 18 
embryos (data not shown). Thus, we conclude that in the absence of NIK signaling, 
embryonic Vγ5+ precursors are developmentally blocked and as a result fail to 
populate the epidermis. This is similar to the phenotype previously reported in a 
mutant mouse strain (FVB/N mice from Taconic Laboratories) lacking thymic 
expression of Skint-1, which is a positively selecting ligand required for developing 
DETCs (Boyden et al., 2008; Lewis et al., 2006). 
 
THYMIC NIK-/- DETC PRECURSORS ARE REDIRECTED TOWARDS THE IL-17 LINEAGE 
Recently, it has been proposed that a molecular mechanism dependent on the 
transcription factors Egr3, RORγt and Sox13 determines whether developing γδ 
T cells will progress towards a T-bet dependent IFN-γ producing lineage, or towards 
an RORγt dependen IL-17 producing lineage (Turchinovich and Hayday, 2011). The 
default transcriptional program for DETC precursors depends on selection by Skint-1 
(Turchinovich and Hayday, 2011), which also causes the upregulation of skin-
homing receptors and the subsequent migration to the epidermis (Xiong et al., 
2004). 
We wanted to test whether NIK deficient DETC precursors not only show a 
developmental block, but also deviate from their default transcriptional program of 
T-bet driven IFN-γ production. To do so, we analyzed thymic γδ T cell precursors 
isolated from d19 embryos for their ability to produce IFN-γ and IL-17. 
While for Vγ4+ thymocytes no relevant differences in their cytokine profile could be 
detected, Vγ5+ DETC precursors isolated from NIK-/- animals showed a marked 
switch towards an IL-17 producing profile, with up to 50% of cells expressing IL-17 
(Figure 10a and b). This was accompanied by a reduced ability for production of 
IFN-γ. Furthermore, this change in the functional profile of immature DETCs was 
also detected at embryonic day 18 and in newborn pups (data not shown). 
Hence we conclude that in the absence of NIK, developing DETC precursors not only 
show a developmental block in terms of surface marker expression, but also change 
their default transcriptional program towards the IL-17 lineage. 
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SKINT-1 EXPRESSION IS REDUCED IN NIK-/- MTECS 
Given that NIK-/- animals have a disturbed thymic architecture with undefined 
cortico-medullary junction and smaller medulla (Kajiura et al., 2004), one possible 
explanation for the observed DETC phenotype in NIK-/- thymi could be loss of Skint-1 
expression (Boyden et al., 2008; Lewis et al., 2006). Therefore, we sort purified 
MHC-II+ EpCAM+ mTECs from the thymi of adult NIKaly/aly and NIKaly/wt control 
animals and analyzed the expression of Skint-1 by qPCR. As has been reported by 
other groups, fewer mTECs both in frequency and absolute numbers could be 
recovered from NIKaly/aly thymi than from control animals (Akiyama et al., 2008; 
Figure 10: Thymic Vγ5+ DETC precursors in NIK-/- animals are redirected towards 
the IL-17 producing lineage. 
(A) Flow cytometric analysis of Vγ4+ and Vγ5+ thymocytes in day 19 embryos for their ability 
to produce IFN-γ and IL-17. NIK+/- control animals are depicted in the upper row, NIK-/- 
animals in the lower row. Left plots are pregated on CD45+ live singlets. (B) Quantification 
of IFN-γ and IL-17 production by Vγ4+ thymocytes (left plots) and Vγ5+ thymocytes (right 
plots). 
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Kajiura et al., 2004). Also, the proportion of mTECs was shifted more towards 
immature MHC-II low mTECs. Analysis of the Skint-1 expression level showed a 
roughly 75 % reduction in NIKaly/aly animals compared to controls. Also, expression of 
Aire was strongly reduced in NIKaly/aly mTECs, which is in line with previous reports 
showing reduced Aire expression in NFκB2-/- mice (Zhu et al., 2006). 
Thus, our results suggest that the observed DETC defects in the absence of NIK 
signaling are caused by the loss of Skint-1 expression in mTECs. However, we also 
wanted to test this hypothesis in a genetic model. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DELETION OF NIK IN MTECS DOES NOT INFLUENCE THE DETC COMPARTMENT 
The developmental block of embryonic DETC precursors seen in NIK-/- mice could 
reflect either a cell intrinsic role of NIK signaling in Vγ5+ thymocytes, or rather a cell 
extrinsic mechanism involving medullary thymic epithelial cells (mTECS). Indeed, 
recent reports suggested a model in which RANK-RANKL interactions between 
developing γδ thymocytes and immature mTECs are essential for the maturation of 
Aire+ mTECs, which in turn via Skint-1 promote the further development of Vγ5+ 
DETCs (Roberts et al., 2012). 
Figure 11: Loss of Skint-1 expression in NIKaly/aly mTECs. 
(A) Flow cytometric gating strategy for sorting of EpCAM+ MHC-II+ mTECs from NIKaly/wt 
controls (middle plot) and NIKaly/aly animals (right plot). (B) Reanalysis of the sorted 
population. (C) qPCR analysis of Skint-1 and Aire expression by mTECs. 
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To test this hypothesis, we collaborated with Lucas Onder (Cantonal Hospital St. 
Gallen), who recently generated a novel BAC-transgenic mouse line expressing Cre 
recombinase under control of the CCL19 promotor, which is active in LN stromal 
cells and mTECs (Chai et al., 2013; Misslitz et al., 2004). By crossing this mouse line 
to the conditional NIKflox/flox strain (see next chapter), NIK should be deleted 
specifically from the mTEC compartment, but not from γδ T cells. Indeed, 
preliminary data generated by Lucas Onder suggests that in adult CCL19-Cre 
NIKflox/flox animals the thymic medulla is almost completely absent. 
Analysis of the epidermal immune compartment in adult CCL19-Cre NIKflox/flox 
animals revealed a normally appearing DETC compartment, both in terms of 
absolute numbers as well as Vγ5 expression. This would suggest that in contrast to 
the current belief, γδ T cell intrinsic NIK signaling is required for DETC development. 
 
 
 
  
Figure 12: DETC development is not impaired after mTEC specific deletion of NIK 
using CCL19-Cre NIKflox/flox mice. 
Flow cytometric analysis of the epidermal γδ T cell compartment in CCL19-Cre NIKflox/flox mice 
(lower row) and Cre negative control animals (upper row). Plots are pregated on CD45+ 
CD11b- live singlets. Plots on the right show the frequency of total γδ T cells as well as Vγ5+ 
DETCs. 
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NIK SIGNALING IS ESSENTIAL FOR IL-17 PRODUCTION BY LYMPHOID γδ T CELLS 
Based on the unexpected role of NIK signaling in DETC development we speculated 
that also other γδ T cell subsets might depend on NIK for their function. Therefore, 
we aimed at characterizing the composition and functionality of different lymphoid 
and tissue-resident γδ T cell populations in the absence of NIK signaling.  
 
 
Figure 13: Phenotypic analysis of the lymphoid γδ  T cell compartment in NIK-/- 
mice. 
(A) Gating strategy used for analysis of lymphoid γδ T cells. (B) Flow cytometric analysis of 
splenic γδ T cells for the presence of Vγ4+ and Vγ1.1+ subsets and CD27 expression. (C) 
Quantification of total, Vγ4+ and Vγ1.1+ γδ T cells, in frequency of parent, as well as CD27- 
Vγ4+ γδ T cells. 
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In the lymphoid circulation of naïve mice, the majority of γδ T cells can be 
categorized into two subtypes expressing the Vγ4 and the Vγ1.1 chain, according to 
the nomenclature of Heilig and Tonegawa (Heilig and Tonegawa, 1986). 
Furthermore, some γδ T cells are characterized by CD27 expression, which has been 
correlated with the ability to produce IFN-γ, while CD27- γδ T cells tend to express 
IL-17 (Ribot et al., 2009). The majority of IL-17-producers have been shown to 
express Vγ4 and Vγ6 TCR chains, whereby the latter are restricted to the lung and 
the uterine tract (Cua and Tato, 2010; Kisielow et al., 2008). 
In the spleen of NIK-deficient animals, the proportions of total γδ T cells as well as 
the Vγ4+ and the Vγ1.1+ subpopulations were comparable to heterozygous controls. 
Also, the distribution of CD27+ and CD27- cells was similar (Figure 13b and c). 
 
 
Figure 14: Lymphoid γδ  T cells in NIK-/- mice are impaired in IL-17 production.  
(A) Flow cytometric analysis of IFN-γ and IL-17 production by ex vivo isolated splenic γδ 
T cells in NIK+/- control (upper row) and NIK-/- animals (lower row). Plots have been pregated 
on CD45+ CD11b- live singlets. (B) Quantification of cytokine production by splenic γδ T cells. 
(C) Sorted splenic γδ T cells were stimulated for 48 hours with platebound anti-CD3 and IL-
2, followed by intracellular cytokine staining. Left plot depicts NIK+/-, left plot NIK-/- γδ T cells. 
Pregating was done on live CD3+ TCRγδ+ cells. 
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However, when splenic γδ T cells from NIK-/- mice were assessed for their ability to 
produce IFN-γ and IL-17 after restimulation with PMA and Ionomycin, we noted that 
NIK deficient γδ T cells completely lost IL-17 expression, while they maintained the 
capacity to produce IFN-γ (Figure 14a and b). As has been reported previously, the 
majority of IL-17 producing cells were confined to the Vγ4+ subsets of γδ T cells 
(data not shown) (Cua and Tato, 2010). 
Notably, this inability for IL-17 production remained even after in vitro stimulation 
with αCD3 and IL-2 (Figure 14c), a regimen that has been previously described for 
activation of γδ T cells (Ribot et al., 2009). This strongly suggests that NIK-signaling 
is essential for the “thymic imprinting” (Jensen et al., 2008) of γδ T cells towards the 
IL-17 producing lineage. Very recently, a similar phenotype has been reported to be 
caused by RelB deficiency in γδ T cells (Powolny-Budnicka et al., 2011). Given that 
RelB is a downstream target of NIK, this corroborates the notion that non-canonical 
NFκB signaling is an important driver enabling IL-17 secretion by γδ T cells. 
 
NIK IS ESSENTIAL FOR IL-17 PRODUCTION BY LUNG-RESIDENT Vγ6+ γδ T CELLS 
Based on the phenotype observed in lymphoid Vγ4+ γδ T cells we wanted to assess 
IL-17 production by another highly specialized γδ T cell subset, namely lung-resident 
Vγ6+ γδ T cells. In ontogeny, these cells develop immediately after Vγ5+ DETC 
precursors, and in contrast to them will migrate preferentially to the lung epithelium 
and the reproductive tract (Carding and Egan, 2002; Itohara et al., 1990). Vγ6+ cells 
can be identified by the use of the clonotypic antibody 17D1 (Roark et al., 2004).  
Steady-state analysis of the lung of adult NIK-/- mice revealed that both Vγ4+ and 
Vγ6+ subsets were present, albeit there was a conspicuous reduction in the 
frequency and staining intensity of Vγ6+ γδ T cells (Figure 15a and b). When we 
assessed their ability for production of IFN-γ and IL-17, Vγ4+ cells similar to the 
situation in the spleen showed strongly reduced IL-17 production, while the level of 
IFN-γ remained comparable to controls (Figure 15a and c). For Vγ6+ cells the 
situation was more variable, but we also observed a 30-80% reduction in the 
frequency of IL-17+ cells (Figure 15a and c). Notably, these cells were unable to 
produce any IFN-γ at all. 
Therefore, we conclude that in the absence of functional NIK signaling, both Vγ4+ 
and Vγ6+ γδ T cells in the periphery and in non-lymphoid tissues are unable to 
produce pro-inflammatory IL-17. Further work is needed to elucidate the underlying 
mechanism, in particular whether NIK signaling is needed in a γδ-intrinsic manner, or 
rather in other (stromal) cell types. 
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Figure 15: Vγ4+ and Vγ6+ lung γδ  T cells in NIK-/- animals are impaired in IL-17 
production.  
(A) Flow cytometric analysis of IFN-γ and IL-17 production by ex vivo isolated lung γδ T cells 
in NIK+/- control (upper row) and NIK-/- animals (lower row). Plots have been pregated on 
CD45+ CD11b- CD4- live singlets. (B) Frequency of Vγ4+ (left plot) and Vγ6+ (right plot) 
γδ T cells in the lung. (C) Frequency of IL-17 producing Vγ4+ (left plot) and Vγ6+ (right plot) 
γδ T cells in the lung. 
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NIK SIGNALING AND THE INDUCTION OF CELL-MEDIATED IMMUNITY 
GENERATION OF A NOVEL CONDITIONAL MOUSE LINE: NIKFLOX/FLOX 
As discussed in the introduction, it is by now widely accepted that NIK signaling 
fulfills diverse roles in different cellular compartments. However, studying the 
precise function of NIK in individual cell types in vivo has proven to be difficult 
because of the diverse phenotypes found in complete knockout animals. Hence, 
there is a need for a novel conditional mouse model that would allow cell-type 
specific deletion of NIK. 
Since it was first reported in the 1980s that homologous recombination in murine 
embryonic stem (ES) cells can be used to genetically target mice (Thomas and 
Capecchi, 1987), researchers were seeking for a system that would allow tissue-
specific gene knockouts in vivo. The Cre-LoxP system has been found to be suitable 
for targeted recombination (Orban et al., 1992; Sauer and Henderson, 1988), and 
shortly after that the first T cell specific knockout was generated by the Rajewsky 
lab (Gu et al., 1994).  
Loxp sites are 34 base pair long DNA sequences, which are recognized by the 
bacteriophage P1 derived DNA-recombinase Cre. This recombinase can be expressed 
under a tissue specific promotor, leading to recombination and thus deletion of the 
LoxP-flanked target gene only in that particular tissue. 
In general, for the generation of mice carrying a LoxP flanked allele, a bacterial 
targeting vector is generated that contains two homology arms, an antibiotic 
resistance gene, and at least one essential exon of the gene of interest which is 
flanked by LoxP sites. This vector is introduced into murine ES cells in vitro by 
electroporation, followed by screening and selection of ES cell clones that have 
successfully integrated the targeting vector by homologous recombination. These ES 
cells will then be injected into blastocysts, which after implantation into a 
pseudopregnant foster mother will give rise to chimeric offspring. These chimeras 
will consist of a mixture of cells containing either the targeted or the wildtype allele. 
In case the injected ES cells formed the germ cells of these chimeric animals, the F1 
offspring will carry the conditional allele and can be further bred to homozygosity. 
In an initial attempt to generate a conditional NIK allele, we designed and cloned a 
vector targeting exon 3 of the NIK genomic locus (also known as Map3k14 locus), 
which was verified by restriction digests and sequencing (data not shown). However, 
after electroporation and selection of JM8N6 ES cells, the screening of more than 
600 ES cell clones both by Southern Blot and long range PCR did not yield any 
homologously recombined clones (data not shown) and hence we abandoned this 
approach. 
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Therefore, in collaboration with the lab of Ari Waisman in Mainz (Germany) and 
Taconic-Artemis in Cologne (Germany) an alternative targeting strategy was 
designed, which employed slightly different homology arms, thereby targeting Exons 
4-6 of NIK. Using this approach, targeted ES cells as well as chimeric animals 
carrying the conditional allele (NIKflox/wt) were successfully generated by Taconic-
Artemis. These mice were crossed to Flp-deleter animals to remove the Neomycin 
resistance cassette, followed by breeding to homozygosity and to two different Cre 
lines: CD4-Cre, which would delete NIK in all αβ T cells (Wolfer et al., 2001), and 
CD11c-Cre, which would delete NIK in all dendritic cells (Caton et al., 2007; 
Stranges et al., 2007). Furthermore, in collaboration with Lucas Onder from the 
Cantonal Hospital of St. Gallen, NIKflox/flox mice were crossed with a CCL19-Cre line, 
which is active in lymph node stromal cells as well as medullary thymic epithelial 
cells (Chai et al., 2013). 
CD11c-Cre NIKflox/flox and CD4-Cre NIKflox/flox mice were born at normal Mendelian 
ratio and appeared fertile and healthy without obvious defects. Of note, in contrast 
to the complete NIK knockout, both lines showed normal presence of lymph nodes. 
In order to assess the functionality of the conditional allele and the deletion 
efficiency after Cre-mediated recombination, we sort-purified CD4+ T cells, 
Figure 16: Targeting vector used for the initial generation of a conditional NIK 
allele in ES cells. 
The targeting vector consisted of a short and long arm of homology, the frt flanked 
Neomycin resistance (NeoR) cassette, the LoxP flanked Exon 3 and the thymidine kinase 
gene used to reduce the number of ES cell clones integrating the vector at a random site in 
the genome. The restriction sites used for the Southern Blot screening of the ES cell clones 
are not depicted.  
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CD11c+MHC-IIHI DCs and CD19+ B cells from the spleen of CD11c-Cre NIKflox/flox, 
CD4-Cre NIKflox/flox and littermate control animals (Figure 18a). Reanalysis of the 
sorted populations confirmed their purity to be routinely above 95% (Figure 18b). 
Following RNA isolation and cDNA synthesis, we performed quantitative real-time 
PCR (qPCR) analysis for the expression level of NIK mRNA.  
In T cells obtained from CD4-Cre NIKflox/flox animals, the expression of NIK mRNA 
was more than 90% reduced compared to control animals, while there was no 
change neither in B cells nor in DCs (Figure 18c). In contrast, CD11c-Cre NIKflox/flox 
mice showed the same expression level of NIK in T cells and B cells, while in DCs 
the expression was reduced approximately 70-80%, indicating that deletion took 
place. 
 
 
Figure 17: Targeting strategy used by Taconic-Artemis to generate a conditional 
NIK knockout allele. 
Upper row depicts the genomic locus of NIK (Map3k14), with 16 known exons (blue) and the 
untranslated regions (shown in shaded blue). The translation initation codon for NIK is 
situated in Exon 2. Second and third row show the targeting vector and the genomic locus 
after homologous recombination in ES cells. 
After Flp mediated recombination the Neomycin and Puromycin resistance genes will be 
excised, leaving Exons 4-6 directly flanked by LoxP sites. Cre mediated recombination will 
produce a frameshift in all subsequent Exons, leading to a premature Stop Codon in Exon 7, 
which will target the resulting transcript for nonsense mediated RNA decay. 
(Graphic taken and modified from Taconic-Artemis) 
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Based on this data we assumed that the conditional NIK allele was functional, and 
that deletion in T cells and DCs occurred at a good efficiency. However, given the 
incomplete deletion in DCs, we crossed NIKflox/flox mice to another CD11c-Cre-line 
obtained from the lab of Boris Reizis (Columbia University, New York, USA), which 
has been reported to be more efficient (Caton et al., 2007). Unless stated otherwise, 
subsequent experiments have been performed with the latter line. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Deletion of NIK in CD4-Cre NIKflox/flox and CD11c-Cre NIKflox/flox mice 
occurs at a good efficiency. 
(A) Gating strategy used to sort CD11c+ MHC II+ DCs, CD4+ T cells and CD19+ B cells from 
the spleen. (B) Reanalysis of sorted populations (no upstream gating beside a FSC threshold 
was applied). (C) qPCR analysis of sorted populations for the expression level of NIK in 
wildtype controls (black bars), CD11c-Cre NIKflox/flox (grey bars) and CD4-Cre NIKflox/flox cells 
(grey shared bars). Expression level of the WT has been assigned the value of 1.  
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Figure 19: DCs in CD11c-Cre+ NIKflox/flox mice show impaired IL-12/23p40 
production. 
Splenic DCs were isolated by magnetic enrichment using CD11c-Microbeads (clone N418) 
and stimulated with αCD40 antibodies for 16 hours. For the last 4 hours of stimulation, 
Brefeldin A was added. (A) Gating strategy used for intracellular IL-12/23p40 staining in 
CD11c+ MHC-II+ DCs. (B) IL-12/23p40 expression by NIK+/- control (left), NIK-/- (middle) 
and CD11c-Cre+ NIKflox/flox (right) DCs. (C) Quantification of IL-12/23p40 positive cells after 
αCD40 stimulation (left plot) or of unstimulated (right plot) cells. (D) Quantification of IL-
12/23p40 in the supernatant by ELISA. (E) Median fluorescence intensity of CD80 and CD86 
expression by stimulated CD11c+ MHC-II+ DCs. 
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FUNCTIONAL CHARACTERIZATION OF THE DC-SPECIFIC DELETION OF NIK 
Several reports from our lab (Hofmann et al., 2011) and others (Lind et al., 2008) 
suggested that NIK signaling seems to play a particularly important role in the 
function of DCs. CD40, which is a main activating receptor for DCs, has been shown 
to signal via NIK (Garceau et al., 2000), and NFκB2 activation has been implicated in 
the ability of DCs for cross-presentation (Lind et al., 2008).  
To clarify whether the conditional allele is fully functional and whether DCs in 
CD11c-Cre NIKflox/flox animals resemble some of the phenotypes described in 
complete knockouts, we MACS purified splenic CD11c+MHC-II+ DCs from CD11c-Cre 
NIKflox/flox, NIK-/- and control animals and stimulated them in vitro overnight with 
agonistic αCD40 antibodies. After that, we assessed the expression of CD80, CD86 
and MHC class II as well as the ability for IL12p40 secretion by intracellular cytokine 
staining. 
While there was no detectable difference in the expression level of costimulatory 
molecules such as CD80 and CD86, DCs from CD11c-Cre NIKflox/flox secreted 
significantly less IL12p40 as revealed by intracellular cytokine staining (Figure 19b 
and c), similar to the phenotype previously reported for NIK-/- animals (Hofmann et 
al., 2011). This difference was already detectable without stimulation via CD40. To 
verify the ICS data, we collected supernatants from the in vitro cultured DCs and 
performed ELISA for IL12p40. Both in anti-CD40 stimulated as well as in 
unstimulated samples the amount of p40 in the supernatant was significantly 
decreased in CD11c-Cre NIKflox/flox and NIK-/- DCs compared to controls (Figure 19d). 
Thus, we conclude that DC-specific deletion of NIK impairs the ability of splenic DCs 
to secrete pro-inflammatory IL-12. Notably, this defect is not only noticeable after 
anti-CD40 stimulation, but also in unstimulated DCs. Based on these phenotype we 
conclude that the conditional allele is working as expected. 
 
As a next step, we wanted to analyze the steady state T cell compartment of CD11c-
Cre NIKflox/flox for any irregularities. Flow cytometric analysis of splenocytes showed 
that a normal frequency of CD4 to CD8+ αβ T cells, and also the ratio of CD62L+ 
CD44- naïve to CD62L- CD44+ T cells was comparable between CD11c-Cre NIKflox/flox, 
NIK-/- and control animals (Figure 20a and c). FoxP3+ Tregs were found in similar 
frequencies in CD11c-Cre NIKflox/flox and control animals, but in lower numbers in 
NIK-/- mice, as reported previously (Hofmann et al., 2011). Also, the γδ T cell 
compartment appeared normal in terms of absolute numbers and expression of 
CD27 (Figure 20a and c). Hence we conclude that DC-specific deletion of NIK does 
not lead to any obvious disturbance of the T cell compartment. 
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After we had clarified that the conditional allele is working and does not cause any 
obvious disturbances in the T cell compartment, we sought to clarify whether the DC 
compartment of CD11c-Cre NIKflox/flox animals appears normal. For this, we focused 
particularly on the DC populations in the lymph node because it is not possible to 
study these in straight NIK-/- mice due to the complete absence of lymph nodes. Up 
to now, several distinct populations of DCs have been identified in skin-draining LNs: 
Figure 20: The steady state T cell compartment of CD11c-Cre+ NIKflox/flox animals 
appears phenotypically normal. 
(A) Flow cytometric analysis of the frequency of CD4+ T cells and CD44+ CD62L- effector 
T cells in the spleen of control (upper row), CD11c-Cre+ NIKflox/flox, and NIK-/- animals. (B) 
Flow cytometric analysis of the γδ T cell pool. (C) Summary of the frequency of of CD4+ 
T cells and CD44+ CD62L- effector T cells as well as FoxP3+ Tregs. (D) Summary of the 
frequency of total and CD27- γδ T cells. 
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the MHC-IIlow DC compartment can be separated into CD8+ and CD11b+ 
conventional DCs (cDCs), and the MHC-IIhigh compartment contains Langerin- and 
Langerin+ DCs, the latter representing DCs that migrate from the skin to the draining 
LN (Henri et al., 2001; Randolph et al., 2005; Salomon et al., 1998; Stoitzner et al., 
2003). When we assessed the steady state LN compartment of CD11c-Cre NIKflox/flox 
animals, we found similar proportions of MHC-IIhigh and MHC-IIlow DCs (Figure 21a 
and b). Also the frequency of CD11b+ and CD8+ cDCs was comparable to control 
animals (data not shown).  
 
 
Figure 21: Selective Loss of Langerin+ DCs in the skin-draining lymph node of 
CD11c-Cre+ NIKflox/flox animals. 
(A) Flow cytometric analysis of the steady state DC compartment in the skin-draining lymph 
node of Cre negative control (upper row) and CD11c-Cre+ NIKflox/flox (lower row) mice. Left 
plots have been pregated on CD45+ B220- live cells. Far right plots indicate CD11b 
expression on MHC-IIlow DCs. (B) Quantification of the frequency of MHC-II high and low 
DCs (C) Quantification in terms of frequency (left plot) and absolute number of Langerin+ 
CD11c+ MHC-IIhigh cells. 
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However, when we analyzed the Langerin+ MHC-IIhigh compartment in CD11c-Cre 
NIKflox/flox mice, we found a striking reduction both in frequency as well as absolute 
numbers (Figure 21a and c), that was accompanied by an increase in CD11b+ DCs. 
The proportion of CD103+ cells within Langerin+ DCs did not change. 
Given that all Langerin+ DCs in the lymph node migrate there from the skin, we 
analyzed the dermal DC compartment of CD11c-Cre NIKflox/flox animals. Suprisingly, 
both the total CD11c+ MHC-II+ DC pool as well as the percentage of Langerin+ DCs 
was similar between CD11c-Cre NIKflox/flox and control mice (Figure 22a and b). 
Thus, it seems that DC intrinsic loss of NIK signaling interferes with the migration of 
Langerin+ DCs from the skin to the lymph node. However, further experimentation is 
needed to investigate the underlying mechanism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DC-SPECIFIC DELETION OF NIK LEADS TO EAE RESISTANCE 
Previous work from our lab suggested, that the EAE resistance of complete NIK-/- 
animals can be attributed to a DC defect (Hofmann et al., 2011). However, 
contradictory results have been reported (Jin et al., 2009). Therefore, we wanted to 
revisit the role of NIK in EAE development using our novel conditional mouse model. 
EAE was induced by subcutaneous immunization with MOG/CFA in CD11c-Cre 
NIKflox/flox and control animals. 
Figure 22: Langerin+ DCs are present at normal numbers in the dermis of CD11c-
Cre+ NIKflox/flox mice. 
(A) Lymphocytes were isolated from the dermis for flow cytometric analysis and pregated on 
CD45+ B220- live cells. Middle and right plot show the frequency of Langerin+ DCs. (B) 
Quantification of the percentage of total DCs (left) and Langerin+ DCs (right). 
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Figure 23: CD11c-Cre+ NIKflox/flox animals are resistant to the development of EAE. 
(A) CD11-Cre+ NIKflox/flox (squares) and control B6 mice (circles) were immunized with 
MOG/CFA and monitored for their disease score. (B) Gating strategy used for the analysis of 
CNS infiltrating lymphocytes. (C) Flow cytometric analysis of the CNS infiltrates in control 
animals (upper panel) and CD11-Cre+ NIKflox/flox on day 15 post immunization. (D) 
Quantification of total CD45+ CD11b- infiltrating cells and CD4+ T cells. (E) Flow cytometric 
analysis of the percentage of Foxp3+ Tregs (left plots) and GM-CSF, IFN-γ and IL-17 
production within CNS infiltrating CD4+ T cells. 
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While the controls developed normal paralysis, no clinical signs of disease were 
observed in CD11c-Cre NIKflox/flox mice (Figure 23a). Analysis of CNS infiltrating cells 
on day 15 post immunization showed very few infiltrating T cells (Figure 23c and d), 
and within these cells the expression of pro-inflammatory cytokines remained much 
lower than in control mice. Also, very few FoxP3+ Tregs were detected (Figure 23e). 
For subcutaneous antigens such as during MOG/CFA immunization, skin draining 
DCs play an important role for priming of antigen specific T cells. Thus, we wanted 
to verify whether the deficiency of Langerin+ DCs in the lymph node that we 
observed in steady state CD11c-Cre NIKflox/flox animals also remained in inflammatory 
conditions. To this end, we analyzed the inguinal and axillary lymph nodes for the 
presence of different DC subsets on day 15 post immunization. 
 
Figure 24: Under inflammatory conditions, Langerin+ DCs in the skin draining LN 
are reduced in CD11c-Cre+ NIKflox/flox animals. 
(A) Flow cytometric analysis of the DC populations in the skin draining LN of control (left 
panel) and CD11c-Cre+ NIKflox/flox mice on day 15 post immunization with MOG/CFA. Plots 
have been pregated on CD45+ live singlets. Langerin+ MHC class IIhigh DCs represent skin-
draining Langerhans cells and Langerin+ dermal DCs, Ly6+ CD11b+ MHC class IIlow DCs 
represent monocyte derived inflammatory DCs. (B) Quantification in frequency of parent of 
the indicated DC subsets. 
Results 62 Florian Mair 
Indeed, the number of MHC-IIhigh Langerin+ DCs was again strongly reduced in 
CD11c-Cre NIKflox/flox lymph nodes, while the other DC subsets including cDCs were 
present in numbers comparable to controls (Figure 24a and b). For Ly6C+ 
inflammatory DCs there was a slight, but non-significant trend towards higher 
proportions. 
 
T CELL-SPECIFIC DELETION OF NIK 
Despite our previous work arguing for a critical of NIK in the context of EAE solely in 
DCs (Hofmann et al., 2011), we wanted to analyze whether T cell specific deletion of 
NIK would also influence the disease progression. For this, we immunized CD4-Cre 
NIKflox/flox mice with MOG/CFA. As shown before (Figure 18), NIK is efficiently deleted 
from the αβ T cell compartment of CD4-Cre NIKflox/flox mice. 
 
 
Figure 25: CD4-Cre+ NIKflox/flox animals are resistant to the development of EAE. 
(A) CD4-Cre+ NIKflox/flox (triangles) and control B6 mice (circles) were immunized with 
MOG/CFA and monitored for their disease score. (B) Gating strategy used for the analysis of 
CNS infiltrating lymphocytes. (C) Flow cytometric analysis of the CNS infiltrates in control 
animals (upper panel) and CD4-Cre+ NIKflox/flox on day 15 post immunization. (D) 
Quantification of total CD45+ CD11b- infiltrating cells and CD4+ T cells. 
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Surprisingly, T cell specific deletion of NIK also led to a complete lack of clinical EAE 
symptoms (Figure 25a). In the CNS of CD4-Cre NIKflox/flox mice on day 15 post 
immunization we could not detect any inflammatory infiltrates, and very few CD4+ 
T cells were present (Figure 25c and d). Preliminary analysis of the cytokine 
production by CD4+ T cells in CD4-Cre NIKflox/flox mice showed major impairments 
(data not shown). This suggests, that contrary to our previous hypotheses (Hofmann 
et al., 2011), T cell intrinsic NIK signaling does play a role for the induction of cell-
mediated immunity. Hence, further work is needed to analyze the T cell intrinsic role 
of NIK in more detail in this novel conditional model. 
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DISCUSSION 
 
During the past 20 years the NFκB family of transcription factors has been 
established without doubt as one of the most important regulators of the innate and 
adaptive immune system (Li and Verma, 2002; Pasparakis, 2009; Vallabhapurapu 
and Karin, 2009). However, the dazzling complexity of signaling pathways 
converging to one particular NFκB dimer has made it difficult to study and 
understand the functions of NFκB in straight knockout models, which also often are 
embryonically lethal (Doi et al., 1997). Therefore, immunologists have turned to 
studying individual receptors that lead to NFκB activation, as well as the molecules 
relaying signals from cell surface receptors to NFκB. 
Among these, non-canonical NFκB signaling via the NFκB-inducing kinase (NIK) has 
turned out to be one of the most interesting pathways. Initially, its primary role was 
seen in the development of secondary lymphoid tissues (Shinkura et al., 1999; Yin et 
al., 2001), but during the past decade reports from many groups have established 
that NIK signaling is essential in many compartments of the immune system. Within 
the scope of this discussion, we will focus on the role of NIK in cell-mediated 
immunity and EAE as a model of autoimmunity, and in the development and 
function of γδ T cells. In the end, we will also discuss the role of NIK in the 
development of thymic stromal cells and open questions regarding T cell tolerance. 
 
NIK SIGNALING AND γδ  T CELL FUNCTION 
NIK AND DETC DEVELOPMENT 
Dendritic epidermal T cells, despite being present only in the murine epidermis, have 
emerged as an interesting model population to study the mechanism underlying 
development and function of tissue resident γδ T cell subsets. Several aspects of the 
molecular network governing DETC development have been unraveled recently, in 
particular the fact that the development of thymic Vγ5+ DETC precursors depends on 
expression of Skint-1 by thymic epithelial cells (Barbee et al., 2011; Boyden et al., 
2008; Lewis et al., 2006). Although Skint-1 does not seem to be a ligand for the 
canonical Vγ5Vδ1 TCR, it induces a signaling cascade leading to expression of DETC 
marker genes such as Lymphotactin (Xcl1), but also T-bet, which from studies in αβ 
T cells is known to induce a transcriptional program enabling IFN-γ production. In 
the absence of Skint-1 signals, Vγ5+ thymocytes fail to upregulate T-bet, but instead 
start transcription of RORγt which enables these DETC precursors for production of 
IL-17 (Turchinovich and Hayday, 2011). 
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We found a similar functional switch in Vγ5+ DETC precursors isolated from NIK-/- 
thymi, posing the obvious question as to whether NIK deficient mTECs lack 
expression of Skint-1. Supporting this hypothesis, in preliminary experiments we 
found reduced Skint-1 expression in NIK-/- mTECs, which could explain the 
developmental block of Vγ5+ thymocytes. However, is NIK involved in signaling 
within the γδ T cell compartment, or within mTECs, or both? Very recently, the 
group of Graham Anderson reported data supporting a model in which Vγ5+ 
precursors interact via RANK-RANKL with immature thymic epithelial cells, thereby 
inducing their functional maturation towards Aire+ mTECs, which in turn via Skint-1 
will stimulate the development of Vγ5+ thymocytes towards mature DETCs (Roberts 
et al., 2012).  
This convincing and simple model would provide a compelling explanation for the 
DETC phenotype observed in NIK-/- mice, since RANK signals via NIK (Darnay et al., 
1999). However, in RANK-/- mice (also known as TNFRSF11a or CD265) (Roberts et 
al., 2012), the number of DETCs in the neonatal epidermis was only reduced, while 
in NIK-/- animals we could detect almost no DETCs. This suggests that in the 
absence of RANK another surface receptor, probably LTβ-receptor, generates 
sufficient signal to generate a partial DETC population. Of note, the majority of 
DETCs found in the adult epidermis of RANK-/- animals retain expression of Vγ5+ 
(Roberts et al., 2012), while in NIK-/- animals on average 50% of the γδ T cells 
present in the epidermis express another γδ TCR specificity, that we were unable to 
identify so far. 
Most importantly, up to date no genetic models have been employed to clarify 
whether RANK or LTβR signals are truly only necessary in the mTEC compartment. 
Several lines of evidence hint towards this model (Akiyama et al., 2008; Hikosaka et 
al., 2008; Roberts et al., 2012), but we wanted to use the novel conditional NIK 
mouse line to validate this hypothesis, and found surprising results. Despite an 
almost complete absence of EpCAM+ medullary regions in adult CCL19-Cre NIKflox/flox 
thymi (personal communication, Lucas Onder), we could detect neither a reduction 
nor any phenotypical change in the epidermal DETC compartment.  
This would suggest that NIK signaling in mTECs is dispensable for the formation of a 
normal DETC pool, but there are several explanations for this unexpected finding: 
first, it could be possible that instead of the reported role in the stromal 
compartment, γδ T cell intrinsic NIK signaling is essential. To test this hypothesis, we 
are currently in the process of generating Lck-Cre NIKflox/flox mice, in which both αβ 
and γδ T cells will be devoid of NIK (unfortunately, no γδ T cell specific Cre line is 
available yet). Second, it could be possible that the CCL19-Cre transgene does not 
target immature embryonic mTECs, and that NIK signaling in these early cells is 
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sufficient to drive DETC development. Therefore, we are planning to breed a 
Keratin5-Cre line (Tarutani et al., 1997) with NIKflox/flox animals, which should target 
already the earliest mTEC precursors (Rodewald, 2008). 
 
THE ROLE OF NIK IN CYTOKINE SECRETION BY γδ T CELLS 
In addition to the impaired DETC development, we have observed that the lack of 
NIK-signaling specifically impairs IL-17 production by mature lymphoid and tissue-
resident γδ T cells, while their ability to secrete IFN-γ remains intact. This is 
particularly intriguing since for the majority of γδ T cells, their functional profile is set 
during thymic development, seemingly in dependence of self-antigen encounter 
(Jensen et al., 2008; Ribot et al., 2009). Moreover, the development of IL-17 
producing γδ T cells seems to be supported by the thymic microenvironment only 
within a small developmental window early in ontogeny (Haas et al., 2012; Prinz et 
al., 2013). A prototypic population exemplifying this concept are Vγ6+ γδ T cells, that 
in ontogeny develop immediately after Vγ5+ DETCs, and are among the most potent 
producers of IL-17 of all γδ T cells (Shibata et al., 2008). Also, Vγ4+ γδ T cells, that 
can be found both in the spleen and the dermis, contain a major fraction of IL-17 
producing γδ T cells (Carding and Egan, 2002). 
However, when we analyzed embryonic Vγ4+ thymocytes for their ability to produce 
IL-17, we could not observe any impairment in NIK-/- thymocytes compared to their 
controls. The same was true for Vγ6+ embryonic thymocytes (data not shown). This 
is perplexing, as adult splenic Vγ4+ γδ T cells were almost devoid of IL-17 producing 
cells, and even in vitro culture with agonistic TCR stimulation was not able to evoke 
significant IL-17 production. One possible explanation for that could be that IL-17 
producing γδ precursors start developing in the thymus, but are not able to complete 
their maturation program and either die by apoptosis or undergo functional re-
programming, similar to our experimental observations for NIK-deficient DETCs. Yet, 
preliminary time-course experiments in NIK-/- animals show that Vγ4+ thymocytes on 
embryonic day 17, day 19 as well as 6 days after birth are capable of IL-17 
production similar to heterozygous controls. So far we have not analyzed the 
peripheral γδ T cell compartment in young animals after birth, to see at which stage 
their ability for IL-17 production becomes lost. 
Notably, RelB has already previously been described as a factor conferring the ability 
of IL-17 production to γδ T cells (Powolny-Budnicka et al., 2011), corroborating the 
observations that we have made using NIK-/- mice. Nevertheless, while the report 
from the group of Falk Weih presents solid data for a model in which γδ T cell 
intrinsic LTβ-receptor signaling confers full functionality to γδ T cells, it was 
published at a time when it was not known yet that only the embryonic or newborn 
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thymus can mediate γδ17 T cell development (Haas et al., 2012). Therefore, the 
precise contribution of the NIK-RelB axis to the specialized thymic microenvironment 
during early ontogeny has not been clarified completely, particularly to which extend 
stromal cell types might influence this process. In this context, our novel conditional 
NIK mouse model will be extremely helpful in order to remove NIK signaling 
specifically only in T cells or in mTECS. 
In addition, two very fascinating mysteries of γδ T cell development remain 
unsolved: why do particular TCR specificities home only to particular tissues? And 
what mechanism selects these specificities (Vantourout and Hayday, 2013)? For 
Vγ5+ DETCs the molecule Skint-1 has provided an answer, but no such molecule has 
been identified neither for Vγ4+ dermis-homing nor for Vγ6+ lung-homing γδ T cells. 
Interestingly, a recent study, in which different γδ thymocytes based on their TCRγ 
chain expression were transcriptionally profiled, suggested that there are three 
distinct gene-expression programs: Vγ4+/Vγ6+ IL-17 producing γδ T cells, Vγ5+ 
DETCs and Vγ1+/ Vγ7+ γδ T cells (Narayan et al., 2012). This tripartite separation 
suggests that other instructive clues beside Skint-1 might exist. Given that the 
absence of NIK specifically impairs only some functional aspects in γδ T cells it might 
be possible, that conditional deletion of NIK will yield further insights into the 
mechanism underlying the induction of these transcriptional programs. 
 
NIK AND CELL-MEDIATED IMMUNITY 
 
Studying the molecular pathways that govern the induction of cell-mediated 
immunity (CMI) enables us not only to understand immune responses against 
pathogenic microorganisms, but also the underpinnings of pathologic autoimmune 
responses.  
Within the past years, a major focus of our lab has been the understanding of non-
canonical NFκB signaling via NIK in the context of autoimmune neuro-inflammation. 
We could previously show that induction of autoreactive T cell responses proceeds 
unrelated to the presence or absence of secondary lymphoid tissues (Greter et al., 
2009), and instead NIK signaling plays a mandatory role in dendritic cells for the 
induction of EAE (Hofmann et al., 2011). However, there have been contradictory 
interpretations, with some groups claiming T cell intrinsic impairment of TH17 
differentiation in the absence of NIK (Jin et al., 2009). Given the complicated models 
used previously (Hofmann et al., 2011), the only way to irrevocably answer this 
controversy is a genetic model. The conditional NIKflox/flox strain that we have 
described in this thesis will be the indispensable model for this. 
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T CELL SPECIFIC DELETION OF NIK 
The results obtained so far point towards an essential role of NIK signaling in both 
compartments, αβ T cells and DCs. CD4-Cre NIKflox/flox animals were fully resistant to 
EAE development, but within the available time we were not able to characterize this 
mouse strain in more detail yet. Preliminary data suggest that T cells isolated from 
CD4-Cre NIKflox/flox mice fail to acquire their full functional potential after activation, 
with reduced levels of pro-inflammatory cytokines being produced, and as a result 
they fail to migrate into the CNS. This is similar to T cells isolated from full NIK 
knockout mice, but how does this reconcile with our previous findings, that NIK-/- 
T cells can be fully functional in the presence of NIK-sufficient DCs (Hofmann et al., 
2011)? The used model system of a DC-specific inducible NIK allele (Sasaki et al., 
2008) bred onto a NIK-/- background (DCNIK-NIK-/- animals) was inherently complex, 
and it could be that overexpression of NIK in DCs induced some mechanism that led 
to T cell hyper-reactivity. Furthermore, it has been reported that CD11c-Cre can 
cause recombination within a small fraction of T cells, thus leading to a NIK-
sufficient T cell pool. The conditional CD4-Cre NIKflox/flox will allow investigating these 
uncertainties in more detail.  
Furthermore, we are currently breeding CD4-CreERt2 NIKflox/flox mice, in which Cre 
activity can be induced in CD4+ T cells in a time-specific manner by the 
administration of Tamoxifen (Anna Sledzinska, PLOS Biol 2013 in press). In these 
animals we will be able to delete NIK only in mature αβ T cells but not in developing 
thymocytes, which will help to dissect the roles of NFκB during T cell development 
(Siebenlist et al., 2005) from its function in mature T cells. 
It has also been reported before that NIK signaling might have differential roles in 
naïve and memory αβ T cells (Ishimaru et al., 2006; Rowe et al., 2013), and that in 
the absence of NIK the frequency and function of FoxP3+ Tregs is impaired (Lu et 
al., 2005). We have observed the same Treg phenotype in our own studies 
(Hofmann et al., 2011). Again, it will be interesting to disconnect these phenotypes 
from the role of NIK in other cell types, particularly the thymic stroma, and analyze 
the function of different αβ T cell subsets using the CD4-Cre NIKflox/flox model. 
Furthermore, CD4-CreERt2 NIKflox/flox animals would be a unique tool for deletion of 
NIK in vivo after induction of a T cell response, which might help to clarify the 
proposed role of NIK in the memory T cell pool.  
 
NIK SIGNALING AND DENDRITIC CELL SUBSETS 
Only in the past decade it was appreciated that DCs not only consist of a 
homogenous CD11c+ MHC class II+ population, but rather of distinct subsets with 
specific transcriptional programs (Merad et al., 2013). To study the function of these 
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subsets in detail, there is a tremendous need for tools and molecules to target only 
single DC subsets. Not many of these have been defined yet, except two examples: 
Loss of BATF3 (also known as basic leucine zipper transcription factor ATF-like 3) 
causes a selective absence of CD8+ and CD103+ cDCs (Hildner et al., 2008), and 
knockout of the helix-loop-helix transcription factor E2-2/Tcf4 causes the specific 
loss of plasmacytoid DCs (Cisse et al., 2008). 
Here, we have found that DC-specific deletion of NIK causes a selective reduction of 
migratory Langerin+ cDCs in the skin-draining lymph nodes both under steady state 
and inflammatory conditions. Surprisingly, neither Langerin+ dermal DCs nor 
epidermal Langerhans cells showed any obvious phenotypical differences in CD11c-
Cre+ NIKflox/flox animals. Therefore, it seems that NIK signaling is either essential for 
the migration of skin DCs to the draining LN, or for their survival within the LN, 
which we have to address in further experiments. 
Already in the 1990s LTα (which is upstream of NIK) has been implicated in 
regulating the number of DCs in peripheral lymphoid organs (Wu et al., 1999). In 
line with this, a DC-intrinsic requirement for LTβ-receptor signaling in maintaining 
the lymphoid DC population was reported (Kabashima et al., 2005) . Also, in the 
absence of RelB the numbers of both thymic DCs (Burkly et al., 1995) and splenic 
CD8- DCs (Wu et al., 1998) are strongly reduced. In line with this finding, the 
knockout of TRAF-6 also causes a loss of CD8- splenic DCs (Kobayashi et al., 2003). 
Since both TRAF-6 and RelB are directly upstream and downstream of NIK, 
respectively, it is surprising that in NIKaly/aly mice the frequencies of CD8+ and CD8- 
DCs in the spleen were found to be comparable to controls (Lind et al., 2008). 
However, all the above-mentioned knockouts have several impairments in stromal 
cell function and hence splenic structure, which in turn again might influence the DC 
pool. Furthermore, the contribution of LTβ−receptor signaling via NIK in non-
lymphoid tissue DCs has not been investigated yet. The CD11c-Cre+ NIKflox/flox mice 
will provide a unique tool to address these open questions. 
 
In the context of EAE, the absence of skin-draining DCs in the lymph node would 
provide a simple and plausible explanation for the EAE resistance observed in 
CD11c-Cre+ NIKflox/flox mice, since it has been reported that after depletion of 
Langerin+ CD103+ DCs, subcutaneous immunization with MOG/CFA causes only mild 
EAE with a delayed disease onset (King et al., 2010). This notion has been 
challenged by a subsequent report using a genetic model, namely Batf3-/- mice that 
specifically lack all CD11b- DCs. Despite the complete loss of dermal CD103+ DCs, 
these mice developed normal EAE (Edelson et al., 2011). Given this finding, the 
reason for the EAE resistance in CD11c-Cre+ NIKflox/flox mice must be more complex. 
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In line with our published data on NIK-/- DCs (Hofmann et al., 2011) and previous 
work by others (Lind et al., 2008), we found reduced production of IL12/23p40 by 
DCs isolated from CD11c-Cre+ NIKflox/flox mice. As a next step, it would be interesting 
to dissect whether there is a selective effect on either secretion of IL-12 or IL-23, as 
the latter is absolutely essential for the induction of pathogenic, autoreactive T cells 
(Cua et al., 2003). Furthermore, we plan to analyze the ability for production of 
other pro-inflammatory cytokines such as IL-6. 
 
Notably, it has already been reported before that NIKaly/aly splenic DCs are impaired 
in their ability for cross-priming (Lind et al., 2008). In the same study, gene profiling 
of splenic NIKaly/aly DCs revealed that after in vivo stimulation with anti-CD40 a 
plethora of genes relevant to DC function failed to be upregulated, including IL-6, 
CD86 and CD274 (Programmed Death Ligand-1). However, by now it is well 
established that DCs differ in their function depending on their anatomic location, 
and obviously it is inherently impossible to study LN-resident DCs in NIKaly/aly or NIK-/- 
animals because of the complete lack of LNs. Hence, to expand previous findings on 
DC function (Lind et al., 2008), we plan to analyze the effects of DC-specific deletion 
of NIK in-depth in different DC subsets both in lymphoid and non-lymphoid tissues. 
 
NIK SIGNALING AND THE ESTABLISHMENT OF CENTRAL TOLERANCE 
 
As discussed above and in the introduction, T cell function has extensively been 
studied in NIKaly/aly and NIK-/- mice, with varying experimental interpretations 
(Ishimaru et al., 2006; Lu et al., 2005; Matsumoto et al., 2002; Rowe et al., 2013). 
One major caveat of some of these studies is that the influence of abolished NIK 
signaling on the development of thymic epithelial cells, and thus on T cell 
development, was ignored. It has been shown without doubt that NIKaly/aly mice, 
similar to TRAF-6-/- and RelB-/- animals do not form a structurally normal thymic 
medulla, with decreased numbers of mature mTECs (Akiyama, 2005; Burkly et al., 
1995; Kajiura et al., 2004). Promiscuous gene expression of tissue restricted self-
antigens, which is executed by mTECs under control of the Autoimmune regulator 
(Aire) (Mathis and Benoist, 2009), is an essential tolerance mechanism both for 
purging the developing T cell repertoire of self-reactive specificities and for the 
induction of Tregs (Anderson et al., 2002; Aschenbrenner et al., 2007). Furthermore, 
it has been postulated that a small population of so-called natural TH17 cells is 
selected in the thymus based on interaction with MHC class II on mTECs, similar to 
agonist induced selection of Tregs (Kim et al., 2011). Also, previously published data 
from our lab support a model in which thymic DCs in the absence of NIK influence 
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the developing T cell pool in terms of its effector function (Hofmann et al., 2011). 
Therefore, it is inherently difficult to disconnect any T cell phenotype from the 
thymic impairments seen in straight NIK-/- animals, even with the use of bone 
marrow chimeric approaches. 
The conditional NIKflox/flox allele will for the first time allow studying the role of NIK 
signaling in the T cell compartment and in mTEC development and central tolerance 
induction separately. In collaboration with the Institute of Immunobiology in St. 
Gallen we have crossed CCL19-Cre NIKflox/flox animals, in which Cre will be active in 
stromal cells of the lymph nodes and mTECs (Onder et al., 2013). According to 
preliminary data, in CCL19-Cre NIKflox/flox thymi NIK is specifically deleted in mature 
MHC-IIhigh mTECs. As a result, the structure of the thymic medulla is almost 
completely eliminated, and instead a population of immature CD205+ EpCam+ 
mTECs accumulates (data generated by Lucas Onder, Figure 26). While it has 
already been reported before that signaling events from the LTβ-receptor and RANK 
are important for the formation of the mTEC network (Boehm et al., 2003; Hikosaka 
et al., 2008; Rossi et al., 2007), this mouse model will allow to investigate the 
development of the thymic stroma, and the resulting impact on the developing T cell 
pool in much more detail than previously possible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26: Deletion of NIK in mTECs causes loss of the thymic medulla 
Microscopic analysis of the thymi of adult control (left panel), CCL19-Cre+ LTβ−Rflox/flox 
(middle panel) and CCL19-Cre+ NIKflox/flox animals. Green represents CCL19-YFP, red staining 
for CD4, and blue staining for EpCam (marking mTECs). Pictures and data have been 
generated by Lucas Onder, Cantonal Hospital of St. Gallen. 
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Beside mTECs, thymic DCs are essential for deleting auto-reactive thymocytes 
(Gallegos, 2004), and also the induction of Tregs (Proietto et al., 2008). Previous 
work in our lab suggests that in the absence of NIK signaling, thymic DCs are 
impaired in their functional capacity, and they produce less of the chemokines 
needed for the guided migration of developing thymocytes (Hofmann et al., 2011). 
Again, it has not been clarified, if these phenotypes are caused by impaired DC-
intrinsic NIK signaling or by the inherent structural defects in complete NIK-/- mice. 
Hence, it will be interesting to investigate whether CD11c-Cre+ NIKflox/flox mice show 
any defects in thymic DC function and T cell development, which for time reasons 
we were unable to analyze yet. 
 
NIK SIGNALING – NON-CANONICAL ONLY? 
 
The notion of two separate signaling entities driving the activation of distinct NFκB-
dimers has been widely accepted since its initial discovery (Dejardin et al., 2002; 
Malinin et al., 1997). However, there is accumulating evidence that this strict 
separation does not always reflect reality, as some reports show that NIK can signal 
into the classical pathway. First, depending on the upstream receptor engaged, NIK 
seems to engage either the classical or the non-canonical pathway (Ramakrishnan et 
al., 2004). Also, it has been suggested that NIK is able to “amplify” classical NFκB 
activation (Zarnegar et al., 2008). 
Along these lines, preliminary data from our lab indicate that the downstream target 
of NIK might not necessarily be only NFκB2 (Janin Hofmann, personal 
communication): Lethally irradiated wild-type animals that were reconstituted with 
RelB-/- bone marrow (hence having a RelB deficient hematopoietic compartment) 
were fully susceptible towards the development of EAE, which is the opposite of the 
phenotype observed in wild-type chimeras reconstituted with NIK-/- bone marrow. 
Also, NFκB2-/- animals have been reported to have normal numbers of FoxP3+ Tregs 
in the periphery (Zhu et al., 2006), while our own data show that both NIKaly/aly and 
NIK-/- mice have a 50% reduction in the frequency of Tregs (Hofmann et al., 2011). 
Finally, very recent work implementing mathematical modeling of signaling pathways 
suggests, that RelB can be a target of classical NFκB signaling (Shih et al., 2012). 
Clearly, further biochemical studies are needed to understand the intracellular 
signaling network of NFκB activation in more detail, but it can be said without doubt 
that signals relayed via NIK play distinct roles in the activation of various immune 
cells. 
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CONCLUDING REMARKS 
 
For a long time, NIK deficient mice have served as an animal model for studying 
immune responses in the absence of lymph nodes. Only within the past decade it 
became evident that loss of NIK leads to cell-intrinsic defects in various immune 
compartments, including B cells, T cells, DCs and stromal cells. Previous work from 
our lab has identified NIK as an essential signaling entity for the development of 
EAE, irrespective of the lack of lymph nodes in NIK-/- animals, thus emphasizing the 
need to understand the function of NIK particularly in T cells and DCs. 
 
Within this thesis, I have identified additional functions for NIK in the γδ T cell 
compartment: First, NIK signaling is essential to provide γδ T cells with the ability to 
produce IL-17. Second, in the absence of NIK, the epidermal DETC pool cannot form 
normally. The precise underlying mechanism seems to be centered on the function 
of NIK in thymic epithelial cells, but further work is needed to delineate the series of 
events that allow for normal development of γδ T cells. 
 
Furthermore, I have described a novel conditional mouse model, that for the first 
time allows the cell-type specific deletion of NIK without confounding effects from 
the structural deficits in complete knockout models.  
In line with previous data from our lab, DC-specific deletion of NIK causes mice to 
be resistant towards the development of EAE. Furthermore, NIK signaling seems to 
play very specific roles for the normal migration and function of DCs in the lymph 
node. Additional experiments using CD11c-Cre NIKflox/flox mice will yield further 
insight into the function of NIK signaling in DCs beyond its known role in relaying 
CD40-signals. 
 
In summary, the conditional NIK mouse line described here will be very useful to 
add further insight into the role of NIK signaling within the immune system. 
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MATERIALS AND EXPERIMENTAL PROCEDURES 
 
MICE AND ANIMAL EXPERIMENTS 
All mice were kept in-house in individually ventilated cages under specific pathogen-
free (SPF) conditions. C57BL/6 (wild-type) mice were purchased from Janvier. 
NIKflox/wt mice were generated by Taconic-Artemis (Cologne, Germany) and 
maintained in our facility. CD11c-Cre mice were generously provided by Boris Reizis 
(Columbia University, New York, USA), and CD11c-Cre-GFP mice were obtained from 
Alexander Chervonsky (Jackson Laboratory, Ben Harbor, USA). CD4-Cre mice were 
obtained from Jackson Laboratories. CCL19-Cre mice were generated by Lucas 
Onder (Chai et al., 2013) and crossed with NIKflox/flox mice at the Cantonal Hospital 
St. Gallen. 
To obtain embryos of a specifc age, timed matings were set up: male and female 
mice were mated over night, and females were observed for signs of pregnancy. 
Pregnant females were euthanized by CO2 inhalation, embryos were removed and 
euthanised by decapitation. 
Experimental autoimmune encephalomyelitis (EAE) was induced as described 
previously (Gyülvészi et al., 2009). Briefly, mice were immunized subcutaneously 
with 200 µg of MOG35-55 peptide (MEVGWYRSPFS-RVVHLYRNGK; GenScript) 
emulsified in CFA (Difco) in a total volume of 200 µl and two intraperitoneal 
injections of 200 ng Pertussis toxin (Sigma) on day 0 and 2. For passive EAE 
experiments, spleen and lymph node cells were harvested from donor mice of the 
indicated genotype on day 7 post immunisation, restimulated in vitro for two days 
with 20 µg/ml MOG and 10 ng/ml IL-23 and then i.v. transferred to sublethally (550 
Rad) irradiated WT or Rag1-/- recipients. 
All animal experiments were approved by local authorities (Kantonales Veterinäramt, 
Zurich) and performed under the appropriate experimental license (55-2009 and 86-
2012). 
 
DNA ISOLATION AND GENOTYPING 
Biopsies were obtained either by ear-punching adult mice, or by toe-clipping pups 
before reaching an age of 12 days. Biopsies were incubated in 500 µl tail lysis buffer 
containing 10 µl Proteinase K for 2-6 hours at 55°C, followed by centrifugation for 5 
minutes at 13.000 rpm to pellet undigested tissue. The supernatant was transferred 
to a fresh tube and 500 µl of Isopropanol were added to precipitate the DNA, 
followed by centrifugation for 20 minutes at 13.000 rpm / 4°C. The supernatant was 
discarded, the pellet was washed with 500 µl of 70% Ethanol and centrifuged again 
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for 5 minutes at 13.000 rpm / 4°C. After removal of the supernatant, the DNA 
pellets were air-dried for 10-15 minutes and then resuspended in 50-100 µl of TE 
buffer. If the DNA did not fully dissolve, samples were incubated for 10-15 minutes 
at 55°C. 
For genotyping, 1 µl of the purified DNA was used as template, together with the 
following primers and PCR protocols. PCR products were analyzed by running a 
standard 1-2% agarose Gel in TAE buffer. 
 
NIK-knockout: 
10x buffer containing Mg2+ (New England Biolabs):  3 µl 
dNTPs (10 mM)      1 µl 
5 NIK primer (AGT CCA ATT CCA TGT TGC TGC TGT)  1 µl 
3 Neo primer (ATC TTG TTC AAT GGC CGA TCC CAT)  1 µl 
3 NIK primer (TCT GAG ATA GGC ATA TCC CTG GCT)  1 µl 
DNA template       1 µl 
TAQ polymerase (New England Biolabs)   0.2 µl 
PCR water       21.8µl 
 
Denaturation:   94 °C  4 minutes 
Elongation:  94 °C  30 sec 
60 °C  30 sec 
72 °C  30 sec 
repeat 35 times 
Final elongation: 72 °C  5 minutes 
Hold:   10 °C 
 
Endogenous band: 270 bp 
Recombinant band: 500 bp 
 
NIKflox: 
10x buffer without Mg2+ (New England Biolabs):  2.5 µl 
MgCl2 (50 mM)      1 µl 
dNTPs (10 mM)      0.5 µl 
5 primer (TAT GAA CTG CTC CCG TTT CG)   0.5 µl 
3 primer (CCT GTG CAT CAC AGA GTA TAC TAG C)  0.5 µl 
DNA template       1 µl 
TAQ polymerase (New England Biolabs)   0.2 µl 
PCR water       18.8µl 
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Denaturation:   94 °C  5 minutes 
Elongation:  94 °C  30 sec 
60 °C  30 sec 
72 °C  60 sec 
repeat 35 times 
Final elongation: 72 °C  10 minutes 
Hold:   10 °C 
 
Endogenous band: 357 bp 
Recombinant band: 541 bp 
 
CD11c-Cre 
10x buffer without Mg2+ (New England Biolabs):  2.5 µl 
MgCl2 (50 mM)      1 µl 
dNTPs (10 mM)      1 µl 
5 primer (ACT TGG CAG CTG TCT CCA AG)   0.5 µl 
3 primer (GCG AAC ATC TTC AGG TTC TG)    0.5 µl 
DNA template       1 µl 
TAQ polymerase (New England Biolabs)   0.25 µl 
PCR water       17.25 µl 
 
Denaturation:  94 °C   4 minutes 
Elongation:  94 °C  30 sec 
63 °C  45 sec 
72 °C  60 sec 
repeat 35 times 
Final elongation: 72 °C  10 minutes 
Hold:   10 °C 
 
Recombinant band: 300 bp 
 
CD4-Cre 
10x buffer without Mg2+ (New England Biolabs):  2.5 µl 
MgCl2 (50 mM)      1 µl 
dNTPs (10 mM)      1 µl 
5 primer (CCC AAC CAA CAA GAG CTC AAG G)  1 µl 
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3 primer (CCC AGA AAT GCC AGA TTA CG)    1 µl 
DNA template       1 µl 
TAQ polymerase (New England Biolabs)   0.2 µl 
PCR water       17.3 µl 
 
Denaturation:  95 °C   3 minutes 
Elongation:  94 °C  45 sec 
63 °C  45 sec 
72 °C  60 sec 
repeat 35 times 
Final elongation: 72 °C  5 minutes 
Hold:   10 °C 
 
Recombinant band: 600 bp 
 
CD4-Cre ErT2 
10x buffer with Mg2+ (New England Biolabs):  2.5 µl 
dNTPs (10 mM)      1 µl 
Primer 1 (TCTTAGTTTGGCAGGACCT)   1 µl 
Primer 2 (CGGCATCAACGTTTTCTTTT)    1 µl 
Primer 3 (TCTTCTTCTGGGAACTCTCG)   1 µl 
DNA template       1 µl 
TAQ polymerase (New England Biolabs)   0.25 µl 
PCR water       16.5 µl 
 
Denaturation:   95 °C  3 minutes 
Elongation:  94 °C  45 sec 
63 °C  45 sec 
72 °C  45 sec 
repeat 35 times 
Final elongation: 72 °C  5 minutes 
Hold:   10 °C 
 
Endogenous band: 400 bp 
Recombinant band: 450 bp 
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General Cre PCR 
10x buffer with Mg2+ (New England Biolabs):  1.2 µl 
dNTPs (10 mM)      0.25 µl 
Transgene forw (GCG GTC TGG CAG TAA AAA CTA TC) 1.2 µl 
Transgene rev (GTG AAA CAG CAT TGC TGT CAC TT)  1.2 µl 
Pos ctrl forw (CTA GGC CAC AGA ATT GAA AGA TCT) 1.2 µl 
Pos ctrl rev (GTA GGT GGA AAT TCT AGC ATC ATC C) 1.2 µl 
DNA template       1 µl 
TAQ polymerase (New England Biolabs)   0.1 µl 
PCR water       4.65 µl 
 
Denaturation:   94 °C  3 minutes 
Elongation:  94 °C  30 sec 
51.7 °C 60 sec 
72 °C  60 sec 
repeat 35 times 
Final elongation: 72 °C  3 minutes 
Hold:   12 °C 
 
Cre Transgene: 100 bp 
Internal Control: 324 bp 
 
 
LYMPHOCYTE ISOLATION FROM SPLEEN, THYMUS AND LN 
For isolation of bulk lymphocytes, spleen, thymus and lymph nodes were 
mechanically disrupted using either microscopic glass slides or a syringe plunger and 
a 70 µm cell strainer. For spleens, red blood cell (RBC) lysis was performed using 
1 ml of RBC lysis buffer and 5-10 minutes of incubation on ice, followed by a 
washing step with 10 ml of PBS. Unless stated otherwise, all centrifugation steps 
were carried out for 5 minutes at 500 g / 4°C. 
Embyonic thymi were obtained by decapitating embryos of the indicated 
developmental stage, followed by careful dissection under a stereo microscope 
(Leica). Thymi were disrupted mechanically using a syringe plunger and a 70 µm cell 
strainer. 
For the isolation of DCs from the lymph node, Collagenase D digestion was used: 
lymph nodes were cut into small pieces, incubated in 2 ml of Collagenase D 
(0.4 mg/ml) and DNase (0.1 mg/ml) in RPMI containing 2%FCS and 25mM HEPES 
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for 30-45 minutes at 37°C, followed by mechanical disruption with syringes. The cell 
suspension was filtered though a 70 µm cell strainer and used for further 
procedures. 
 
LYMPHOCYTE ISOLATION FROM CNS 
Mononucleated cells were obtained from CNS tissues as described (Gyülvészi et al., 
2009): mice were euthanized using CO2 inhalation. Afterwards, animals were 
perfused using 25 ml of ice-cold PBS, the spinal cord was flushed out of the spine by 
hydrostatic pressure, and the brain was removed from the scull. Brain and spinal 
cord were pooled and cut into small pieces using scissors, followed by 30-45 minutes 
of digestion with 0.4 mg/ml Collagenase D (Roche) and 0.1 mg/ml DNase (Sigma) in 
IMDM containing 25mM HEPES and 2% FCS at 37°C. The digest was stopped by 
addition of 1:100 of 0.5M EDTA, and remaining pieces of tissue were homogenized 
using syringes and 20 gauge needles. After washing, the cell suspension was loaded 
onto a continuous 28% Percoll (GE) gradient and centrifuged for 30 minutes at 
15.000 g. Myelin was removed from the upper Percoll layer, and mononuclear cells 
were obtained from the interphase, washed twice with PBS and used for further 
procedures. 
 
LYMPHOCYTE ISOLATION FROM THE SKIN 
Isolation of lymphocytes from the murine skin was adapted based on previously 
published protocols (Ginhoux et al., 2009). Unless stated otherwise, ears were used 
as skin samples. Mouse ears were split into dorsal and ventral parts using forceps 
and incubated at 37°C for 90-105 minutes in HBSS (Invitrogen) containing 
Ca2+/Mg2+ and 2.4 mg/ml of Dispase (Sigma). Afterwards epidermal sheets were 
removed from the dermis, and dermis and epidermis were separately cut into small 
pieces using scissors, followed by incubation in HBSS containing Ca2+/Mg2+ and 10% 
FBS and 0.2-0.4 mg/ml Collagenase Type IV (Sigma). The resulting suspension was 
homogenized using syringes and 19 gauge needles, followed by filtering through a 
70 µm cell strainer and further use in downstream applications. 
For embryos, after decapitation the whole body skin was obtained and treated the 
same way as ears. 
 
LYMPHOCYTE ISOLATION FROM THE LUNG 
For lymphocyte isolation from the lung, lungs were collected and cut into small 
pieces using scissors and incubated in 1 mg/ml collagenase D (Roche) and 
0.1 mg/ml DNase (Sigma) in IMDM containing 25mM HEPES and 2% FCS for 
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approximately 60 minutes at 37°C. The digest was stopped by addition of 1:100 of 
0.5M EDTA, and remaining pieces of tissue were homogenized using syringes and 20 
gauge needles. The cell suspension was filtered via 70 µm cell strainers and washed 
with PBS. Red blood cell (RBC) lysis was performed using 1 ml of RBC lysis buffer 
and 5-10 minutes of incubation on ice, followed by a washing step with 10 ml of 
PBS. The obtained cells were used for further procedures. 
 
ENRICHMENT OF THYMIC STROMAL CELLS 
Thymi were cleaned of fat and connective tissue and cut into pieces using small 
scissors, incubated with collagenase/dispase (Roche, final conc. 0.4 mg/ml) 
including DNase (final conc. 0.1 mg/ml) in IMDM containing 25mM HEPES and 2% 
FCS at 37°C for 45 minutes. For each thymus, 1-2 ml of collagenase/dispase 
medium was used. To disrupt cell-cell interactions, the suspension was resuspended 
frequently. After 45 minutes the digest was stopped by addition of EDTA to yield a 
final concentration of 5 mM and incubation for 5 minutes at 37°C. After EDTA 
incubation cells were transferred to ice immediately and washed with PBS. After 
complete removal of the supernatant the pellet was carefully resuspended in high 
density percoll (GE Healthcare, ρ = 1.115, 45.2 g of PBS mixed with 5.217 g of 10x 
PBS). An intermediate layer of low density percoll solution (GE Healthcare, ρ = 1.045 
– 1.06 according to titration, 22.3 g of high density percoll mixed with 26 g of 1x 
PBS) followed by an upper layer of medium was very carefully pipetted to yield an 
inverse discontinous density gradient. 
After centrifugation at 1350 g for 30 minutes at 4°C (without brake, medium 
acceleration) low density cells (including mTECs and DCs) were removed from the 
upper interphase. Cells were washed with PBS und used for subsequent procedures. 
 
FLOW CYTOMETRY 
Flow cytometric analysis was performed following standard methods (reviewed in 
(McLaughlin et al., 2008; Perfetto et al., 2004)). All flourochrome-conjugated 
antibodies used were obtained either from BD, BioLegend or eBioscience and used 
according to titration experiments. Commonly used clones are listed in the table 
below. For all experiments, dead cells were excluded from the analysis using an 
Aqua Live/Dead fixable staining reagent (Invitrogen) (Perfetto et al., 2010), and 
doublets were excluded by FSC-Area vs FSC-Height gating.  
For intracellular cytokine staining, cells were incubated 3-5 hours in IMDM 
containing 10% FCS with PMA (50ng/ml), Ionomycin (500ng/ml) and GolgiPlug 
(containing Brefeldin A, BD, 1:1000 dilution) at 37°C. Cytofix/Cytoperm (BD) was 
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used according to the manufacturers instructions, and Perm/Wash Buffer was either 
obtained from BD or prepared in-house.  
Flow cytometric analysis was carried out using either a FACSCanto II (BD) or a LSR 
II Fortessa (special order research product, BD). Optical configurations of the used 
instruments are listed below. Single stained compensation controls were prepared by 
using anti-rat/hamster Comp Beads and the flourophores used in the particular 
experiment. Cell sorting was carried out using a FACSAria III (BD). Data analysis 
was performed using FlowJo 9.x and 10.0.0.x (TreeStar). 
 
 
Optical configuration of FACSCanto II 
Laser Mirror Filter Used dyes 
Violet 
405nm 
502LP 510/50 AmCyan, Aqua L/D 
  450/50 PacificBlue, BV421 
Blue  
488nm 
735LP 780/60 PE-Cy7 
655LP 670LP PerCP, PerCP-Cy5 
556LP 585/42 PE 
502LP 530/30 FITC 
  488/10 SSC 
Red 
640nm 
735LP 780/60 APC-Cy7 
685LP 660/20 APC 
 
Optical configuration of LSR Fortessa 
Laser Mirror Filter Used dyes 
Violet     
405nm 
735LP 800/50 Brilliant Violet 785 
685LP 710/50 Brilliant Violet 711 
640LP 670/30 Brilliant Violet 650 
600LP 610/20 Brilliant Violet 605 
505LP 525/50 AmCyan, Aqua L/D 
  450/50 PacificBlue, BV421 
Blue        
488nm 
635LP 690/50 PerCP/PerCP-Cy5.5 
505LP 525/50 FITC 
  488/10 SSC 
YellowGreen       
561nm 
750LP 780/60 PE-Cy7 
685LP 710/50 PE-Cy5.5 
635LP 670/30 PE-Cy5 
600LP 610/20 PE-Texas Red, PE-CF594 
  582/15 PE 
Red             
640nm 
750LP 780/60 APC-Cy7 
685LP 730/45 AlexaFluor700 
  670/30 APC 
 
The antibody clones used for flow cytometry experiments were as follows: 
Materials 82 Florian Mair 
Clone Target Manufacturer 
17A2 CD3 eBioscience / BioLegend 
GK1.5 CD4 BioLegend / BD 
53-6.7 CD8 BioLegend / BD 
M1/70 CD11b BioLegend 
N418 CD11c BioLegend 
M1/69 CD24 BioLegend 
PC61 CD25 BD 
LG.3A10 CD27 BioLegend/BD 
IM7 CD44 BD 
30F11 CD45 BioLegend / BD 
C363-16A CD45RB BD 
MEL-14 CD62L BD 
H1.2F3 CD69 BioLegend / BD 
16-10A1 CD80 BioLegend 
GL1 CD86 BioLegend 
2E7 CD103 BioLegend 
TM-β1 CD122 BD 
RA3-6B2 B220 BD 
M5/114.15.2 I-A/I-E BioLegend 
GL3 TCR γδ BioLegend / BD 
2.11 Vγ1.1 BioLegend 
UC3-10A6 Vγ4 BioLegend 
536 Vγ5 BioLegend 
PK136 NK1-1 BD 
Al-21 or HK1.4 Ly6C BD / eBioscience 
1A8 Ly6G BD 
XMG1.2 IFN-γ BioLegend / BD 
TC11-18H10 or 17B7 IL-17 BioLegend / BD 
MP6-XT22 TNFα BioLegend 
MP1-22E9 GM-CSF BD 
FJK-16s Foxp3 eBioscience 
eBioL31 Langerin (CD207) eBioscience 
G8.8 EpCam BioLegend 
 
 
MACS PURIFICATION OF DCS 
For bulk enrichment of splenic DCs, spleens were cut into small pieces with fine 
scissors and incubated in 3 ml of IMDM containing 2% FCS, 25 mM HEPES and 0.4 
mg/ml Collagenase D (Roche) for 30 minutes. Remaining tissue was mechanically 
disrupted using a syringe plunger and a 70 µm cell strainer. RBC lysis was 
performed using 1 ml of RBC lysis buffer and 5-10 minutes of incubation on ice, 
followed by a washing step with 10 ml of PBS. 
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Afterwards, cells were labeled with CD11c-Microbeads (Miltenyi, clone N418) 
according to the manufacturers instructions and positive cells were purified using an 
AutoMACS (Miltenyi). The positive fraction was collected, washed with PBS and used 
for downstream applications. 
 
PREPARATION OF EPIDERMAL SHEETS 
For preparation of epidermal sheets, ears of the indicated genotypes were collected 
and split into dorsal and ventral halves using forceps. Afterwards, ears were 
incubated in 0.5 M Ammonium-Thiocyanate for 90 minutes at room temperature to 
detach the epidermis from the dermis. Epidermal sheets were carefully removed 
using forceps, washed in PBS and mounted on a microscopic glass slide using a fine 
brush. Sheets were allowed to airdry for 25 minutes at room temperature (RT), and 
then incubated in Aceton for 10 minutes at RT. After three consecutive washes in 
PBS containing 1% of Tween, the epidermal sheets were stored at 4°C or directly 
used for staining. For this, the samples were incubated with the respective 
antibodies for at least 6 hours at 4°C (CD3-Bio and Streptavidin AlexaFlour 647, or I-
Ab AlexaFlour 488). 
 
ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 
For the IL-12/23p40 ELISA the corresponding kit was obtained from BD (IL-12 
OptEIA) and used in slightly modified form as follows. Capturing antibody was 
diluted 1:250 in coating buffer, and ELISA plates (BD) were coated with 50 µl per 
well at 4°C over night. Plates were washed with PBS-Tween (1%) for three times 
and blocked with assay diluent (PBS with 10% FBS) for 1 h at room temperature 
(RT). IL-12/23p40 standard (BD) and samples were diluted in assay diluent 
according to the experimental setup, added to the plate in duplicates and incubated 
for 2 hours at RT. After that, the plate was washed with PBS-Tween for five times. 
Biotinylated detection antibody was diluted 1:1000 in assay diluent, 50 µl per well 
were added and incubated for 1 hour at RT. Strepativdin-horseradish peroxidase 
(HRP) was diluted 1:1000 in assay diluent, and 50 µl per well were added and 
incubated for 30 minutes at RT. After 5-8 wash steps with PBS-Tween, 50 µl of 
stabilized chromogen (TMB, Invitrogen) were added. When the highest standard 
reached a dark-blue color, the reaction was stopped by addition of 50 µl of H2SO4. 
Absorption at 450 nm was measured using an ELISA reader. 
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RNA ISOLATION, CDNA GENERATION AND QPCR ANALYSIS 
For RNA isolation sorted cells were pelleted and either stored at -80°C or directly 
processed. 1 ml of Trizol (Applichem) was added, and after thorough resuspension 
cells were incubated for 15 minutes at RT. 200 µl of Chloroform was added, followed 
by mixing. The resulting suspension was transferred to a gel-lock tube and 
centrifuged for 20 minutes at 13.200 g / 4°C. The aqueous (upper) phase was 
transferred to a fresh tube, an equal volume of cooled 70% Ethanol was added and 
mixed. Afterwards, RNA was isolated using the PureLink RNA Micro Kit (Invitrogen), 
following the manufacturers instructions. RNA was eluted in 12 µl of RNAse free 
water. 
10 µl of the resulting RNA solution was heated to 65°C for 5 minutes, quenched on 
ice and used for reverse transcription with M-MLV (Invitrogen) as follows: 
1 µl random primers (100 ng/µl) 
1 µl dNTPs (10 mM) 
4 µl First Strand buffer (5x) 
2 µl DTT (0.1M) 
1 ml RNAse OUT 
1 µl M-MLV reverse transcriptase (200 Units/µl) 
10 µl RNA 
The mixture was incubated for 10 minutes at RT, 50 minutes at 37°C and 15 
minutes at 70°C to inactivate the enzymes. The resulting cDNA was diluted either 
1:5 or 1:10 and used for qPCR using the Invitrogen SYBR Green SuperMix. Reactions 
were run in 384-well plates on a BioRad C1000Touch / CFX384 Real-Time System as 
follows: 
 6.25 µl SYBR-Mix (2x) 
 3.25 µl H2O 
 0.25 µl of each primer 
2.5 µl cDNA 
 
The following primer pairs were used for qPCR amplification: 
PolR2a (145 bp): CTGGTCCTTCGAATCCGCATC 
   GCTCGATACCCTGCAGGGTCA 
NIK (164 bp):  CGAAACTGAGGACAACGAG 
   CACACTGGAAGCCTGTCTG 
Skint-1 (143 bp): TTCAGATGGTCACAGCAAGC 
   GAACCAGCGAATCTCCATGT 
Aire (187 bp):  TGCATAGCATCCTGGACGGCTTCC 
   CCTGGGCTGGAGACGCTCTTTGAG 
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BUFFERS 
FACS buffer: 
 PBS (phosphate buffered saline, Kantonsapotheke Zurich) 
 2% FCS 
 0.005% Sodium Azide 
 
MACS buffer: 
 PBS 
 5 g of bovine serum albumin (BSA, Sigma) 
 4 ml of 0.5M EDTA 
 
Biopsy lysis buffer: 
50 ml 1M Tris/HCl pH 7.5 
5 ml 0.5M EDTA (AppliChem) 
5 ml 20% SDS 
20 ml 5M NaCl 
ad 500ml with H2O bidest 
 
Red blood cell lysis buffer: 
 4.15 g NH4Cl 
 0.55 g KHCO3 
 0.185 g EDTA 
 ad 500 ml with H2O bidest, sterile filtration 
 
Homemade Perm/Wash Buffer: 
PBS 
2% BSA 
0.5% Saponin 
 
TAE buffer (50x): 
 484 g Tris base 
 14.2 ml acetic acid 
 200 ml 0.5M EDTA (pH 8.0) 
 adjust pH to 7.5 
 ad 2000 ml with H2O dest 
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TE buffer: 
 10mM Tris/HCl pH 7.5 
 1mM EDTA (2 ml for 1000 ml of buffer) 
 
Coating buffer: 
0.2 M Sodium Phosphate, pH 6.5 
12.49 g of Na2HPO4, 15.47 g NaH2PO4 
ad 1000 ml with H2O dest 
 
Digestion medium: 
 RPMI (Gibco or PAN) 
 2% FCS 
 25mM HEPES 
 
Cell culture medium for in vitro culture of lymphocytes: 
 IMDM (Gibco) 
 10% FCS 
 Penicillin/Streptomycin 
 L-Glutamine (final conc. 2mM) 
 β-Mercaptoethanol (final conc. 0.5mM) 
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SUMMARY 
 
IL-23 is absolutely crucial for the development of T cell-driven autoimmune disease 
in mice. Even though IL-23 is widely held to be involved in the stabilization of IL-17-
secreting T cells, naïve T cells lack the IL-23 receptor. Thus, the primary cellular 
target of IL-23 in the context of autoimmunity is a subject of some debate.  
Innate lymphoid cells (ILCs) are a recently discovered family of lymphocytes being 
involved in early host defense, particularly at mucosal-epithelial surfaces. Given the 
fact that RORγt dependent ILCs (group 3 ILCs) constitutively express the IL-23-
receptor, and that they have been implicated in intestinal autoimmunity, we 
hypothesized that ILCs could contribute to the early development of autoimmune 
neuro-inflammation. Through systematic analysis we detected a sizable population 
of Thy1+ Sca1+ ILCs in the inflamed CNS tissue. CNS-infiltrating ILCs were 
characterized by expression of the IL-7-receptor and production of pro-inflammatory 
IL-17 and IFN-γ. Furthermore, genetic fate-mapping revealed their dependence on 
the transcription factor RORγt. However, upon specific in vivo ablation of this cell 
population, we found that they do not influence the course of the disease.  
 
 
INTRODUCTION 
 
Over the past 5 years, the term innate lymphoid cells (ILCs) has been coined to 
describe a new family of innate lymphocytes that lack rearranged antigen receptors, 
but share phenotypic and functional characteristics with cells of the adaptive 
immune system. Beside the well-characterized populations of natural killer (NK) cells 
and lymphoid tissue inducer cells (LTIs), several subtypes of ILCs have recently 
been described, both in mouse and human (reviewed in (Spits and Cupedo, 2012) 
and (Spits and Di Santo, 2010)). RORγt+ ILCs, which depend on the retinoic receptor 
related orphan receptor (RORγt) for their development, constitutively express the IL-
23 receptor and are able to produce pro-inflammatory cytokines such as IL-17 and 
IL-22, similar to T cells of the TH17 lineage (Takatori et al., 2009). In contrast, so-
called group 2 ILCs (also known as nuocytes or natural helper cells) were discovered 
as innate producers of IL-5 and IL-13 (Moro et al., 2010; Neill et al., 2010). Very 
recently, a group of researchers has proposed a unifying nomenclature for ILCs, 
which would divide these cells into three subgroups based on their phenotypic and 
functional profile (Spits et al., 2013). 
RORγt+ ILCs (group 3 ILCs) are best known for their non-redundant role during 
formation of secondary lymphoid tissues in embryonic development (Eberl et al., 
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2003), but they also have been suggested to be critical in early host defense in 
different mouse models of infection, in particular in the intestine. For example, after 
infection with Citrobacter rodentium, CD4+ Thy1+ ILCs respond by production of IL-
22 required for bacterial clearance (Sonnenberg et al., 2011). Furthermore, Nkp46+ 
ILCs have been implicated in the maintenance of intestinal homeostasis (Luci et al., 
2009; Sawa et al., 2011). 
In 2010, another unexpected role was attributed to RORγt+ ILCs: Powrie and 
colleagues identified a Lineage- Thy1+ Sca1+ population of ILCs as the main 
mediator of innate IL-23-dependent gut inflammation in Rag-/- mice after infection 
with Helicobacter hepaticus (Buonocore et al., 2010). Of note, a follow-up report 
showed that ILCs are also enriched in intestinal biopsies from patients suffering from 
inflammatory bowel disease (IBD) or Crohns disease (Geremia et al., 2011). These 
unexpected findings suggest that ILCs play a critical role in autoimmune pathology. 
This hypothesis was corroborated by another study, in which lung natural helper 
cells, a population of Type 2 ILCs (group 2 ILCs), were shown to participate 
substantially in allergen-induced airway inflammation, at least in the murine system 
(Halim et al., 2012). Furthermore, it has been suggested that ILCs are able to 
influence adaptive immune responses in general via OX40 ligand signaling to 
memory T cells (Kim et al., 2005; 2003). 
The development of autoimmune neuro-inflammation in the murine system is 
critically dependent on the cytokine IL-23 (Becher et al., 2002; Cua et al., 2003). 
Mice lacking the genes of IL-23, namely Il23a and Il12b or components of the IL-23 
receptor complex are completely EAE resistant.  However, even though IL-23 had 
initially been described to polarize IL-17 secreting auto-aggressive T cells (Langrish, 
2005), it became later clear that other factors initiate the differentiation of TH17 cells 
(Korn et al., 2009). In fact, naïve T cells are unresponsive to IL-23, as they lack the 
appropriate receptor complex (Zhou et al., 2007). Hence the actual function and 
cellular target of IL-23 in the context of neuro-inflammatory disease remains a 
subject of some debate. In contrast to naïve T helper cells, ILCs (as well as γδ T 
cells) are constitutively responsive to IL-23 signaling and thus among the first cells 
sensing IL-23. Indeed, some reports suggested that the immediate IL-23 
responsiveness of γδ T cells can be a critical factor in models of autoimmune 
inflammation (Pantelyushin et al., 2012). 
Thus, we hypothesized that ILCs could also play a role in initiating neuro-
inflammation. So far, outside of lymphoid organs the presence of ILCs has only been 
investigated in the skin, lung and intestine (Spits and Cupedo, 2012). We analyzed 
the central nervous system (CNS) of mice immunized with the immunodominant 
peptide of the myelin oligodendrocyte glycoprotein (MOG35-55) and indeed detected a 
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significant population of lineage negative Thy1+ Sca1+ ILCs, which were able to 
produce both IFN-γ and IL-17. A small population of these cells was also detectable 
in the CNS of naïve animals. Genetic fate-mapping revealed the major fraction of 
these cells belonging to the RORγt-dependent lineage (group 3 ILCs), but a minor 
fraction of CNS-infiltrating ILCs resembled a Thy1+ RORγt-independent lineage 
(group 2 ILCs). However, in vivo ablation of all Thy1+ ILCs demonstrated that these 
cells did not contribute significantly to disease progression, indicating that their 
presence in the CNS is a result of the inflammation dictated by adaptive immunity 
and that their contribution to the inflammatory process is negligible. 
 
 
RESULTS 
 
THY1+ SCA1+ ILCS INFILTRATE THE CNS DURING NEURO-INFLAMMATION  
Phenotypically, the ILC family has been characterized by a large variety of markers, 
which led to a plethora of subtypes and designations for ILCs (Spits and Cupedo, 
2012). Only recently efforts have been undertaken to put forward a uniform 
nomenclature for ILCs (Spits et al., 2013; Walker et al., 2013). Expression of 
markers such as Nkp46, CD117 (c-kit) or CD4 has been reported only in certain 
experimental settings (Buonocore et al., 2010; Eisenring et al., 2010; Spits and 
Cupedo, 2012; Spits et al., 2013). When looking for accordance in the public 
domain, besides being Lineage (lin) negative, all reported subtypes of ILCs express 
IL-7Rα (CD127) – in line with their dependence on common gamma chain cytokines 
for development (Meier et al., 2007) – and Thy1. Thus, for our analysis of ILCs 
during CNS autoimmunity, we focused on the above-mentioned markers as being 
essential for their identification. 
When analyzing the CNS of EAE-diseased wildtype mice by multicolor flow 
cytometry, we used separate fluorescent channels to firmly exclude lin+ cells, 
particularly T cells. Of note, in many published reports lin+ cells were excluded by 
use of a single dump channel (Geremia et al., 2011; Monticelli et al., 2011), ignoring 
the fact that different lineage markers show a high variability in their staining 
brightness. By analyzing the CNS-infiltrating lymphocyte fraction, gating on CD45+ 
CD11b- B220- CD3- CD5- cells revealed a considerable population of Thy1+ Sca1+ 
ILCs expressing IL-7Rα (Fig. 1a). These cells stained negative both for CD4 and 
Nkp46 (Fig. 1b), which is in line with the phenotype attributed to ILCs in intestinal 
autoimmune inflammation (Buonocore et al., 2010). Expression of c-kit (CD117) was 
also not detectable, and only a minor fraction of Thy1+ Sca1+ ILCs expressed Nk1-1. 
 Florian Mair  107 Appendix 
In addition to Thy1+ Sca1+ ILCs a population of Thy1+ Sca1- cells was also 
consistently present in the inflamed CNS. Phenotypic analysis of these cells revealed 
that they did not express the IL-7Rα, but instead NK1.1 and Nkp46 (Fig. 1b), 
suggesting that these cells belong to the NK cell lineage, which have been 
categorized also as group 1 ILCs. Indeed, some NK cells have been reported to 
express Thy1, consistent with our analysis (Kupz et al., 2013). 
To analyze whether CNS-infiltrating ILCs were of the RORγt-dependent lineage, we 
took advantage of a RORc-fatemapping system: Mice expressing Cre-recombinase 
under control of the RORc promotor were crossed to R26-YFPSTOPflox animals. In the 
resulting RORc-YFP mice all cells that once expressed RORγt during their 
development are terminally marked with YFP (Vonarbourg et al., 2010). Indeed, the 
majority of Thy1+ Sca1+ ILCs in the inflamed CNS was positive for YFP (Fig. 1c), 
while a minor fraction of the infiltrating cells seemed to derive from a RORγt-
independend lineage, phenotypically resembling group 2 ILCs. The majority of Thy1+ 
Sca1- cells showed no YFP signal, which is in line with their categorization as NK 
cells (Fig 1c). 
In order to evaluate whether the CNS infiltrating ILCs still express RORγt, we used a 
RORc-GFP reporter strain (Eberl et al., 2003). Interestingly, we found that in the 
inflamed CNS of these animals, only a minority of Thy1+ Sca1+ ILCs retained RORγt 
expression. This is in line with published work by Diefenbach and colleagues 
showing that a sizable fraction of RORγt-dependent ILCs lose RORγt expression 
during their differentiation or activation (Vonarbourg et al., 2010).  
Given the unexpected finding that ILCs can be detected in the CNS during peptide-
induced autoimmune inflammation, we wanted to clarify whether these cells are also 
present under steady state conditions. Using the same gating strategy as in Fig. 1a, 
a small population of Lin- Thy1+ Sca1+ ILCs could consistently be detected in healthy 
wildtype animals (Fig. 1d). To exclude artifacts resulting from a potential inadvertent 
inclusion of T cells, we also analyzed Rag1-/- mice, which completely lack T and B 
cells, as well as TCRβδ-/- mice, which lack all T cells. Indeed, we could verify that the 
CNS of healthy Rag1-/- as well as TCRβδ-/- mice also contained a population of Lin- 
Thy1+ Sca1+ cells. IL-7Rα expression was detectable irrespective of the analyzed 
genotype (Fig. 1d).  
Quantification showed that the amount of ILCs in the CNS during steady state 
conditions, both in absolute numbers as well as in percentage, was similar in WT, 
Rag-/- and TCRβδ-/- animals (Fig. 1e). Due to their lack of lineage markers and their 
rarity, their precise location within the un-inflamed CNS is thus far unclear.  
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Figure 1. Lineage- Thy1+ Sca1+ ILCs invade the central nervous system during 
neuro-inflammation.  
(A) Lymphocytes were isolated from MOG/CFA-immunized WT or heterozygous RORc-GFP 
reporter mice showing an EAE score of at least 2.0 and analyzed by flow cytometry. After 
exclusion of duplets and dead cells, CD45+ lymphocytes were gated for lineage negative 
(CD11b- B220- CD3- CD5-) cells. Upper right panels depict the presence of Thy1+ Sca1+ ILCs 
and Thy1+ Sca1- cells and expression of IL-7Rα (CD127). Data are representative of at least 
three independent experiments, plots show pooled data from three individual CNS samples. 
(B) Further phenotypic analysis of CNS infiltrating Thy1+ Sca1+ ILCs (depicted in red) shows 
no expression of neither CD4 nor Nkp46. Blue histograms show Thy1+ Sca1- cells, and 
shaded histograms show remaining Thy1- Sca-1 cells.  
(C) CNS infiltrating cells were isolated from MOG-immunized RORc-YFP fate-map (left plot) 
or RORc-GFP reporter mice (right plot) and analyzed for YFP and GFP expression, 
respectively. Thy1+ Sca1+ ILCs are depicted in red, Thy1+ Sca1- cells are depicted in blue. 
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(D) Lymphocytes were isolated from the steady-state CNS of wildtype, Rag1-/- and TCRβδ-/- 
mice. Using the same gating strategy as in (A), a comparable population of Thy1+ Sca1+ ILCs 
was detected in all three genotypes. Histograms depict IL-7Rα expression on Thy1+ Sca1+ 
ILCs (red). Data are representative of at least two individual experiments, plots show pooled 
data of three individual CNS samples.  
(E) Quantification of brain-infiltrating Thy1+ Sca1+ ILCs in percentage of CD45+ Lin- cells (left 
panel) as well as absolute cell numbers (right panel). Plots depict individual animals and 
mean +/- SD.  
(F) Quantification of brain-infiltrating Thy1+ Sca1+ ILCs at different timepoints after 
immunization in comparison to healthy controls. Plots depict individual animals and mean +/- 
SD. 
 
 
In contrast to the steady state, a drastic increase in ILCs was observed under 
inflammatory conditions (Fig. 1e), suggesting that Thy1+ Sca1+ ILCs infiltrate into or 
expand in the CNS during experimental autoimmunity. In order to obtain a more 
detailed view on the temporal expansion of ILCs we analyzed the CNS of MOG/CFA 
immunized animals at different time-points post immunization, namely on day 8 
(prior to disease onset), day 13 (peak disease) and day 18 (post peak disease). 
While prior to disease onset very few Thy1+ Sca1+ ILCs could be detected, the 
number of ILCs on day 13 and day 18 post immunization was comparable. However, 
ILCs numbers vary at later disease time points, potentially correlating with the 
extent of remission from the disease. 
 
CNS-INVADING ILCS CONTRIBUTE TO LOCAL CYTOKINE PRODUCTION 
One of the most prominently studied features of RORγt+ ILCs is their immediate 
responsiveness to IL-23 and their ability to produce pro-inflammatory cytokines, 
including IL-17 (Takatori et al., 2009), IL-22 (Luci et al., 2009) but also IFN-γ 
(Buonocore et al., 2010). In innate intestinal inflammation, both IL-17 and IFN-γ 
produced by ILCs have been shown to greatly contribute to  
disease progression(Buonocore et al., 2010). Therefore, we analyzed cytokine 
production of CNS-infiltrating ILCs ex vivo by intracellular cytokine staining and 
found that a large population of Thy1+ Sca1+ ILCs was able to produce IFN-γ, and to 
a lesser extent IL-17 (Fig. 2a). We could not detect any expression of IL-22 (data 
not shown). Analysis of cytokine expression by CNS-resident ILCs during steady 
state showed only minor production of both IFN-γ and IL-17 (Fig. 2b). 
Since PMA/Ionomycin is a very strong activator, we asked whether cytokine 
production by Thy1+ Sca1+ ILCs could be directly induced by stimulation with IL-23. 
Indeed, in vitro culture in the presence of IL-23 induced IL-17 production by CNS 
isolated ILCs comparable to the levels observed with PMA/Ionocycin (Fig 2c).  
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Figure 2: CNS infiltrating ILCs produce proinflammatory cytokines.  
(A) Lymphocytes were isolated from MOG/CFA-immunized wildtype mice showing an EAE 
score of at least 2.0 and restimulated in vitro with PMA/Ionomycin. Using the same linage 
gating strategy as in Fig. 1a, Thy1+ Sca1+ ILCs were analyzed for production of IFN-γ (right 
panel) and IL-17 (middle panel). Plots are representative of at least three independent 
experiments and depict pooled data of three individual CNS samples.  
(B) Thy1+ Sca1+ ILCs isolated from the steady-state CNS of healthy B6 animals were 
restimulated in vitro with PMA/Ionomycin/Brefeldin A and analyzed for production of IFN-γ 
and IL-17. Plots represent pooled data from three individual animals.  
(C) Thy1+ Sca1+ ILCs from MOG/CFA immunized wildtype mice were restimulated in vitro 
with IL-23/Brefeldin A and assessed for production of IFN-γ and IL-17. Flow plots show 
representative data out of two experiments.  
(D) Lymphocytes were obtained from the spleen of MOG/CFA-immunized wildtype mice after 
onset of clinical EAE symptoms (upper panel) as well as healthy controls (lower panel) and 
stained for Lineage- Thy1+ Sca1+ ILCs and IFN-γ and IL-17. Quantification of cytokine 
production is summarized in the two right plots, showing individual animals and mean +/- 
SD.  
(E) Representative plot of Lineage negative Thy1+ Sca1+ ILCs in the spleen of MOG/CFA 
immunized wildtype mice after onset of EAE symptoms and healthy controls. F: 
Quantification of Thy1+ Sca1+ ILCs among total lymphocytes (right plot) and as percent of 
parent Lin- cells (left plot). Plots show individual animals and mean +/- SD. 
 
 
However, very little IFN-γ expression was induced by IL-23, consistent with what is 
known about the impact of IL-23 on ILCs. 
It has already been demonstrated that peripheral ILCs can react very rapidly (within 
hours) to danger signals such as Zymosan (Takatori et al., 2009) or also indirectly to 
TLR-5 stimulation (Van Maele et al., 2010). We thus wanted to determine whether 
the immunization with CFA would trigger systemic ILC expansion in draining lymph 
nodes and thus allow their accumulation within the inflamed CNS. In the peripheral 
immune compartment, we failed to detect any significant difference between ILCs in 
healthy control and MOG/CFA treated animals in terms of cytokine production, 
although there was a slight trend towards increased levels of IL-17 and reduced 
levels of IFN-γ (Fig. 2d). However, after MOG/CFA immunization the total percentage 
of ILCs in the splenic lymphocyte pool increased approximately two to fourfold (Fig. 
2e). 
 
IN VIVO ABLATION OF THY1+ ILCS REVEALS THEIR REDUNDANCE FOR NEURO-INFLAMMATION 
The presence or absence of a cell type in an inflamed organ does not necessarily 
correspond with an important role during disease progression. Such correlative 
observations have often led to erroneous assumptions regarding causal 
relationships. Thus, we decided to systematically test whether the increased number 
of ILCs in the CNS during inflammation has any impact on disease progression or 
severity.  
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Figure 3: Depletion of Thy1+ ILCs does not influence disease progression of EAE. 
(A) Schematic overview of the depletion experiments. Peripheral CD3+ CD4+ T cells from a 
2D2 Thy1.1 donor as well as CD3+CD4+ and CD3+ CD8+ T cells from a Thy1.1 donor were 
sorted, and 2x106 total cells were intravenously transferred to Rag1-/- or RORc-YFP Rag1-/- 
recipients. After allowing for homeostatic expansion of the transferred T cells, mice were 
treated either with depleting anti-Thy1.2 antibody (clone 30H12) or with isotype control at 
the indicated timepoints (“Ab”), followed by immunization with MOG/CFA. Right panels depict 
the purity of the sorted T cells and shows representative data of more than three individual 
experiments.  
(B and C) Efficient depletion of both Thy1+ and Thy1+ YFP+ cells in the spleen (B) and CNS 
(C) was assessed in parallel RORc-YFP Rag1-/- animals after four injections of 200 µg of anti-
Thy1.2 (clone 30H12). For flow cytometric analysis, Thy1.2 was stained using a different 
antibody clone (53.2-1). Representative plots for two individual experiments are shown. 
Right panel shows individual animals, mean +/- SD. (D and E) Disease score after active 
MOG/CFA immunization  
(D) and after passive transfer EAE of in vitro restimulated Thy1.1 T cells into isotype control 
or 30H12-treated Rag1-/- recipients (E). Data are representative of at least three independent 
experiments. Disease scores are shown as mean +/- SEM. 
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To do so, we devised an experimental system that allows selective depletion of all 
Thy1+ ILCs (targeting both group 2 and group 3 ILCs, irrespective of their 
dependence on RORγt) during active immunization, without affecting T cells that 
also express Thy1. CD4+ T cells obtained from TCR-transgenic 2D2 animals (specific 
for the MOG-peptide, (Bettelli et al., 2003)) bred to a Thy1.1 background and CD4+ 
as well as CD8+ T cells obtained from wildtype Thy1.1 animals were sorted to high 
purity (Fig. 3a). A mixture of these T cells was transferred to Rag1-/- recipients with 
a Thy1.2 background.  Hence, the endogenous population of ILCs would express the 
Thy1.2 marker. After three weeks, to allow for homeostatic expansion of the 
transferred Thy1.1+ T-cell populations, depletion of host-derived ILCs was started 
using an anti Thy1.2 antibody (clone 30H12). The experimental layout is 
schematically summarized in Fig. 3a. 
In parallel to the actual immunization experiments, we assessed depletion of 
Thy1+ cells after four injections of 200 µg of anti-Thy1.2. To do so, we used a 
different clone of Thy1.2 for staining (53.2-1) than for depletion (30H12), showing 
that all Thy1+ cells in the spleen were depleted with this protocol (Fig. 3b).  
Furthermore, in this experimental setting we also used RORc-YFP mice bred on a 
Rag-/- background as recipients for the T-cell transfer. In this case, RORγt -
dependent Thy1+ ILCs can be tracked by their expression of YFP. Analysis of spleen 
and also CNS after four injections of anti-Thy1.2 showed that the majority of YFP+ 
cells were depleted in either organ, suggesting that our depletion protocol efficiently 
targets Thy1+ YFP+ ILCs also in the CNS (Fig. 3c). 
After immunization with MOG/CFA, comparison of disease scores between isotype-
treated control animals and ILC depleted animals revealed no difference in disease 
severity and incidence, suggesting that ILCs are superfluous during CNS 
autoimmunity, at least in the EAE model (Fig. 3d). To substantiate this finding, we 
performed passive EAE transfer experiments of in vivo primed Thy1.1 T cells into 
Thy1.2-depleted Rag1-/- recipients, where we also could not detect any differences in 
disease progression after ILC-depletion. (Fig. 3e).  
In summary, our data suggest that during autoimmune neuro-inflammation, Thy1+ 
ILCs do not play a critical role in disease development or progression. 
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DISCUSSION  
 
During the last decade it became obvious that one of the most critical factors in 
many autoimmune pathologies is IL-23. Particularly in neuro-inflammation, IL-23 has 
turned out to be a non-redundant factor, but the mechanism underlying its action is 
far from being understood. IL-23 can trigger differentiation of αβ T cells towards IL-
17 TH17 cells (Langrish, 2005) and GM-CSF producing T cells (Codarri et al., 2011), 
but naïve T cells do not express the IL-23 receptor. In contrast, ILCs as s well as γδ 
T cells have been shown to constitutively express IL-23R, and in the case of γδ T 
cells a significant contribution to the pathogenesis of EAE (Petermann et al., 2010) 
as well as psoriatic skin inflammation has been reported (Cai et al., 2011; 
Pantelyushin et al., 2012). Furthermore, the recent finding that intestinal ILCs via 
expression of MHC class II are able to regulate CD4 T-cell responses (Hepworth et 
al., 2013) further emphasizes their so far underestimated role in the adult immune 
system.  
Along these lines, we hypothesized that ILCs, via their immediate responsiveness to 
IL-23 signals, contribute to autoimmune neuro-inflammation. Further support for 
this hypothesis came from the fact that ILCs are critical players in IL-23 driven 
innate gut inflammation (Buonocore et al., 2010). Indeed, we could show that ILCs 
are not only present at mucosal surfaces as previously reported, but also in the CNS 
both during steady state and inflammation. Based on their surface marker profile, 
the majority of CNS-infiltrating ILCs resembled what had been categorized as RORγt-
dependent, IL-17 producing group 3 ILCs (Spits and Cupedo, 2012; Spits et al., 
2013), with only a minor fraction resembling group 2 ILCs. However, the lineage 
releationships within the ILC family are only starting to be unraveled (Sawa et al., 
2010; Vonarbourg et al., 2010; Walker et al., 2013), and what is now considered to 
be a separate lineage might indeed only represent a different activation state.  
Interestingly, under inflammatory conditions the majority of CNS-infiltrating ILCs 
ceased to express RORγt, in line with published work suggesting that during their 
differentiation certain ILC populations lose RORγt expression (Vonarbourg et al., 
2010). Of note, in this autoimmune colitis model the RORγt and CD4 negative ILC 
population was causative for gut pathology (Vonarbourg et al., 2010). Of note, it has 
also been proposed that expression of T-bet in RORγt+ ILCs can further modulate 
their fate and function, causing a switch from a homeostatic to a pro-inflammatory 
phenotype (Klose et al., 2013). 
Given their presence as a substantial, cytokine-producing population in the CNS, we 
were surprised to discover that depletion of Thy1+ ILCs did not alter progression of 
EAE. There are several possible explanations: First, the widely used immunization 
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protocol utilizing MOG/CFA for induction of EAE might be an inappropriate trigger for 
ILCs. Second, the overwhelming amount of activated, MOG-reactive T cells might 
mask a possibly subtle role of ILCs during the course of autoimmunity. Third, ILCs 
do not play an important role in this particular setting of autoimmune inflammation. 
In summary, we identified a CNS-invading population of group 3 ILCs with the 
capacity to secrete cytokines locally. However, using a functional depletion model 
targeting all Thy1+ ILC subsets we have thoroughly ruled out the involvement of 
ILCs in the pathogenesis of EAE. Nevertheless, since the initial trigger for human MS 
is still unknown, it cannot be excluded that ILCs participate in this primary event. 
Lastly, even though the precise function and cellular targets of IL-23 remain elusive, 
we can herewith exclude a vital role of ILCs as pathologically relevant responders to 
IL-23 during autoimmune neuro-inflammmation. 
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MATERIAL AND METHODS 
 
MICE AND ANIMAL EXPERIMENTS 
C57BL/6 (wildtype), congenic C57BL/6 Thy1.1, Rag1-/-, TCRβδ-/- mice as well as 
Rorc-GFP mice were purchased from Jackson Laboratories and bred in-house under 
specific pathogen-free (SPF) conditions. Rorc-GFP mice were only used as 
heterozygous reporter animals. Rorc-Cre and R26-YFPSTOPflox mice were obtained 
from Andreas Diefenbach and bred in-house either on a WT or a Rag-/- background. 
EAE was induced as described previously (Gyülvészi et al., 2009). Briefly, mice were 
immunized subcutaneously with 200 ug of MOG35-55 peptide (MEVGWYRSPFS-
RVVHLYRNGK; GenScript) emulsified in CFA (Difco) and two intraperitoneal 
injections of 200 ng Pertussis toxin (Sigma) on day 0 and 2. For passive EAE 
experiments, spleen and lymph node cells were harvested from C57BL/6 Thy1.1 
donor mice on day 7 after immunisation, restimulated two days with 20ug/ml MOG 
and 10 ng/ml IL-23 and then i.v. transferred to Rag1-/- recipients. 
 All animal experiments were approved by local authorities (Swiss veterinary office, 
canton Zurich, licence 55/2009 and 85/2012). Depleting antibodies used in some 
experiments (rat-anti-mouse-Thy1.2, clone 30H12 and isotype control ratIgG2b, 
clone LTF-2) were obtained from BioXCell (West Lebanon, USA). 
 
LYMPHOCYTE ISOLATION FROM CNS 
For peak disease analysis, animals were euthanasized on day 13-16 post 
immunization. Mononucleated cells were obtained from CNS tissues as described 
(Gyülvészi et al., 2009): mice were euthanized using CO2 inhalation. Afterwards, 
animals were perfused using ice-cold PBS and brain and spinal cord were collected. 
Tissues were cut into small pieces using scissors, followed by 30 minutes of 
digestion with 0.4 mgl/ml Collagenase D (Roche) and 0.5 mg/ml DNase (Sigma) in 
IMDM containing 25mM HEPES and 2% FCS. Remaining pieces of tissue were 
homogenized using syringes and 20 gauge needles. After washing, the cell 
suspension was loaded onto a continuous 28% Percoll (GE) gradient and centrifuged 
for 30 minutes at 15.000 g. Mononuclear cells were obtained from the interphase, 
washed twice with PBS and used for further procedures. 
  
FLOW CYTOMETRY 
Flow cytometric analysis was performed following standard methods (reviewed in 
(Perfetto et al., 2004)). The flourochrome-conjugated antibodies used were obtained 
 Florian Mair  117 Appendix 
either from BD, BioLegend or eBioscience. In all stainings, dead cells were excluded 
using an Aqua Live/Dead fixable staining reagent (Invitrogen), and duplets were 
excluded by FSC-A vs FSC-H gating. For intracellular cytokine staining, cells were 
incubated 4 hours in IMDM containing 10% FCS with PMA (50ng/ml) / Ionomycin 
(500ng/ml) and GolgiPlug (Brefeldin A, BD). For some experiments, cells were 
restimulated for 4 hours in the presence of IL23-Fc (generated in the lab) and 
GolgiPlug (BD). Cytofix/Cytoperm (BD) was used according to the manufacturers 
instructions. Analysis was performed using a LSR II Fortessa (special order research 
product, BD and equipped with 405 nm, 488 nm, 561 nm and 640 nm laser lines), 
cell sorting was carried out using a FACSAria III (BD). Data analysis was done using 
FlowJo V9.x and 10.0.0.x (Treestar). For some plots, data from several individual 
samples were concatenated (pooled) in FlowJo. 
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